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ABSTRACT 
Measurements of different molecular species from single cells have the potential 
to reveal cell-to-cell variations, which are precluded by population-based measurements. 
An increasing percentage of researches have been focused on proteins, for its central 
roles in biological processes. Immunofluorescence (IF) has been a well-established 
protein analysis platform. To gain comprehensive insights into cell biology and 
diagnostic pathology, a crucial direction would be to increase the multiplexity of current 
single cell protein analysis technologies.   
An azide-based chemical cleavable linker has been introduced to design and 
synthesis novel fluorescent probes. These probes allow cyclic immunofluorescence 
staining which leads to the feasibility of highly multiplexed single cell in situ protein 
profiling. These highly multiplexed imaging-based platforms have the potential to 
quantify more than 100 protein targets in cultured cells and more than 50 protein targets 
in single cells in tissues. 
This approach has been successfully applied in formalin-fixed paraffin-embedded 
(FFPE) brain tissues. Multiplexed protein expression level results reveal neuronal 
heterogeneity in the human hippocampus.  
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CHAPTER 1 
INTRODUCTION 
1.1 Single-cell protein analysis 
Conventional biochemical and molecular assays, while used in studying gene expression 
patterns, signaling networks, and regulatory circuits, provide average features of cell 
propulations1. It is demonstrated by single-cell studies that average results from cell 
populations will hinder cell-to-cell variabilities2,3. Genetic differences, functional states, 
and microenviroments all play critical roles in cell variations4. Even in genetically 
identical cells, cell variations are also universal because of stochastic gene expression5, 
epigenetic markers, alternative splicing, and post-translational modifications6,7. To 
advance our understanding in major fields of human health, such as neuronal science, 
cancer research, and stem cell biology, the resolution of conventional cell-population-
based methods are not yet satisfactory. Therefore, single-cell analysis is critical since it 
can reveal the spatial organization, gene expression regulation and interactions between 
diverse cell types in their complex natural context.  
Cells are composed of a huge collection of molecules of distinct nature. The execution of 
cellular functions, such as self-replication and adaption to external environments, relies 
on the temporal and spatial organizations of biomolecules through highly intricate 
mechanisms8. A global analysis of these biomolecules in single-cell level is the key to 
understand their functions and interactions, also find clues for disease pathogenesis. 
Improvements in sequencing technology facilitate the development of a variety of 
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methods to study DNA and RNA in single cells4,9–12. These methods revolutionized the 
study in single cell genomes and transcriptomes.  
Protein-protein interactions play a principal role in cell functions, such as cell division, 
differentiation, and apoptosis. Consequently, global analysis of proteins, which includes 
protein expressions, abundance, post-translational modifications, and interactions, is 
much anticipated. Other than single-cell genomes and transcriptomes, single-cell 
proteomics will add a new and important dimension to our understanding of cell biology. 
However, the synthesis of proteins goes through a variety of processes including 
alternative splicing, post-translational modification, and degradation8, which make 
capturing the proteomic information to be technically challenging.  
Single-cell protein analysis originates from the development of 2 major techniques: flow 
cytometry/fluorescence-activated cell sorting (FACS)13,14 and fluorescence microscopy15. 
These techniques lead to a lot of discoveries in cell biology and clinical applications. 
However, due to the spectral overlap of organic fluorophores or fluorescent proteins16, 
these methods can only quantify a few proteins in single cells. Other than this, the protein 
expression level in cells follows an extremely wide distribution, the quantification of low 
abundance protein is technically difficult. Unlike nucleic acids, the amplification methods 
of protein are lacking owing to the highly diverse physiochemical properties of amino 
acids, which are the building blocks of proteins. Therefore, to get the global map of 
proteins, new methods need to be developed which have high multiplexity and detection 
sensitivity.  
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Here I review several recent developments of single-cell protein analysis. These methods 
can be classified into 3 categories: microchip, mass spectrometry (MS) – based methods 
and fluorescence microscopy derived methods. These methods together provide a 
systematic way in cell biology and facilitate to unlock mysteries in neuronal science, 
cancer research, and stem cell biology. I will briefly introduce the concepts of these 
technologies, along with their advantages and drawbacks. Additionally, some data 
analysis tools on how to deal with high-dimensional cell data. Finally, I will discuss the 
biomedical applications, current issues, challenges, and potential solutions.  
1.2 Microchip approaches 
The microchip approaches enable the detection of secreted proteins from single cells. 
Such proteins are technically difficult because only hundreds to thousands of proteins are 
secreted from single cells. The microchip approaches capture single cells in small 
chambers in a very small volume (~1 nL) so that the concentration of target proteins is 
compatible with traditional immunoassays. Additionally, the cells can be recovered for 
further characterization.  
The Love group developed microengraving approach17–19. In this approach, an 
elastomeric array of microwells is fabricated, every single cell is confined in one 
microwell in subnanoliter volume. Antibodies corresponding to proteins of interest are 
coated on a glass substrate. The glass substrate is used to temporarily seal the microwell 
array. After incubation, the secreted proteins will be captured by the antibodies on the 
glass substrate. The glass substrate can be stripped off and target proteins can be analyzed 
by sandwich-type ELISA immunoassay. By using spectrally separated fluorophores, 
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these approaches allow the detection of 4 different secreted in parallel. The glass 
substrate can be replaced to achieve kinetic study to cytokines. After microengraving, 
fluorescent antibodies can be applied to the cells to further study other proteins of interest 
so the multiplexity can be increased.  
The Heath group designed single-cell barcode chips (SCBC)20 which dramatically 
increased the multiplexity (Figure 1.8.1). 1040 3-nL microchambers are fabricated on 
each chip. Each microchamber contains a spatially encoded antibody barcode. The 
barcode contains a full library of antibodies corresponding to proteins of interest. The 
barcodes are constructed with DNA-encoded antibody libraries (DEAL) technologies21,22. 
ssDNAs are first immobilized in a polylysine-coated surface in a high density to serve as 
barcodes. Then DNA-antibody conjugates are hybridized to the immobilized ssDNAs. In 
this way, the DNA barcodes are converted to antibody barcodes. One to a small defined 
number of cells is loaded to each microchamber. The secreted proteins are captured by 
antibody barcodes then characterized by immunosandwich assays. With duplicate of 
barcodes in each microchamber, this approach allows the detection of up to 20 protein 
targets in subthousand of single cells. The multiplexity is further improved by the 
combination of spatial and spectral barcodes developed by the Fan Group23. The barcode 
is comprised of 15 stripes. 3 antibodies are immobilized in each stripe. The 3 proteins in 
each stripe can be detected by using 3 spectral separated fluorescent antibodies. This 
approach allows the detection of up to 45 distinct proteins in single cells.  
Other single-cell protein analysis methods, such as MS-based and in situ proteomics 
methods can only characterize membrane and cytoplasmic proteins, SCBC enables the 
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multiplexed detection of secreted effector proteins. It provides a powerful tool to study 
immune-system functions24,25. Additionally, single cells after SCBC can be recovered and 
are compatible with other proteomics assays, which make it possible to detect secreted, 
cytoplasmic and membrane proteins in the same cells. This approach also has some 
limitations. The volume of each microchamber in SCBC needed to be small enough to 
provide a high concentration of secreted proteins, thus increasing the multiplexity by 
increasing number of antibody barcodes will sacrifice the detection sensitivity. Also, the 
fabrication of antibody barcodes could be technically complexed.  
1.3 Mass spectrometry – based single-cell proteomics 
Mass spectrometry has been long used to study proteomics. The first step for 
conventional mass spectrometry protein analysis is cell lysis and protein extraction. The 
proteins are then lysed into peptides and analyzed by liquid chromatography coupled to 
mass spectrometry (LC-MS). Mass spectrometry enables to quantify the absolute number 
of proteins26. However, these results are based on cell populations. To make single-cell 
study available, new technologies need to be developed.  
1.3.1 Single-cell mass cytometry 
To enable single-cell proteomics study, the Nolan group developed single-cell mass 
cytometry27,28, which combines the concept of flow cytometry and the analysis power of 
mass spectrometry (Figure 1.8.2). Conventional flow cytometry uses organic 
fluorophores as signal reporters, thus the multiplexity is limited. In single-cell mass 
cytometry, transition element isotopes are used to label antibodies and then applied to 
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immune assays. Cells, with the elemental reporters, are nebulized into single-cell 
droplets. The cells are vaporized and the isotopes are ionized in an inductively coupled 
argon plasma. The resulting elemental ions are analyzed by a time-of-flight (TOF) mass 
spectrometer. The elemental mass spectrum is then analyzed and translated into protein 
abundances.  
The major advantages of single-cell mass cytometry are high throughput and 
multiplexity. Compare to organic fluorophores, with a large number of transition element 
isotopes available, this approach can label more than 30 proteins in single cells. Also, 
TOF allows the quantification of 1000 cells per second, which makes it the highest 
throughput method among single-cell proteomics to date. However, this method has its 
limitations. This approach loses the subcellular resolutions since the whole cell is 
nebulized and analyzed all at once. It’s difficult to apply this approach in tissue studies 
because it’s technically challenging to segment cells from its natural location. This 
method quantifies only 30%-40% of the cells so that it tends to fail in capturing rare cell 
types with a small number of cells. Finally, the cells can’t be recovered and applied in 
further studies.  
1.3.2 Mass cytometry imaging 
To achieve in situ proteomics detection, multiplexed ion beam imaging (MIBI)29 was 
developed by Nolan lab. In this approach, primary antibodies are coupled with elemental 
isotopes and applied to the immunostaining of the biological samples. A rasterized 
oxygen duoplasmatron primary ion beam strikes the sample spot by spot, the elemental 
isotopes are liberated as secondary ions. The secondary ions are then detected under mass 
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spectrometry which can quantify several lanthanide isotopes simultaneously. The results 
were then analyzed and reconstructed into cell images with information from all the 
target proteins. This approach has a resolution of 200 to 300 nm, which is comparable 
with immunohistochemistry and almost 3 order improvement compare to commercial 
mass spectrometry-based methods.  
A similar method combined the mass spectrometry and immunohistochemistry30 was 
developed almost at the same time as MIBI. The samples are stained with metal isotopes 
and detected by time-of-flight ICP-MS instrument (CyTOF system). This approach 
successfully detected 32 proteins in parallel at a cellular resolution of 1 µm.  
Given dozens of available metal isotopes, these two methods enable the analysis of many 
proteins in single cells. Compare to fluorescence-based methods, these methods avoid the 
autofluorescence generated by biomolecules. The biggest limitation is the throughput. For 
example, to construct an image of 50 to 100 µm, it takes 5 to 25 min with MIBI method. 
This drawback limits the application of these methods to study large numbers of cells.  
1.4 Fluorescence in situ proteomics 
A lot of research has been focusing on cell-cell interactions and protein-protein 
interactions due to their critical roles in cell fates and functions. These studies require the 
analysis of cells performed in their natural context and the characterization of the target 
molecules in their precise subcellular locations. For example, it is demonstrated that 
different spatial distributions of cancer immune cells lead to different tumor-immune 
microenvioments, which determines the various types of cancers and prognosis31.  
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As mentioned above, microchip approaches enclose each cell in a small chamber and 
characterized secreted proteins, single cell mass cytometry vaporize each cell to achieve 
protein analysis. These methods failed to provide the coordination of the cells in tissues 
and the subcellular location of proteins in cells. MS imaging-based methods have high 
resolution and multiplexity. However, given the fact that they need 8 hours to analyze 1 
mm2 of a biological sample, the throughput is not satisfactory. 
Compare to microchip and MS-based methods, fluorescence in situ proteomics have a 
unique advantage which retains the precise location of cells in tissues. Additionally, these 
methods have high throughput and subcellular resolution. Furthermore, these methods 
rely only on widely-used apparatus which are accessible to most of the labs and clinics. 
The multiplexity of conventional immunofluorescence (IF) or immunohistochemistry 
(IHC) is limited due to the spectral overlap of fluorophores. To solve this problem, cyclic 
immunofluorescence is developed32–40. In these methods, antibodies labeled with 
different fluorophores are applied to the immunostaining of the biological samples. The 
biological samples are then imaged under a fluorescence microscope. Finally, the 
fluorescent signal is removed to allow the initiation of the next cycle. Given N spectral 
distinct fluorophores being used in each cycle, with M sequential immunofluorescence 
cycles, M*N protein targets can be characterized in the same specimen. These methods 
emerged as powerful tools in single-cell proteomics.  
1.4.1 Signal removal by photobleaching 
The Schubert designed a photobleaching based method34 to remove fluorescent signals, 
which is also one of the earliest methods that achieve cyclic immunofluorescence. This 
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method requires long time exposure of biological specimens under a light source. 
Additionally, each image area needs to be bleached sequentially. Therefore, this method 
is time-consuming and might lead to photodamage, so the throughput is limited.  
1.4.2 Signal removal by DNA strand displacement 
The Diehl group applied the concept of DNA strand displacement to remove fluorescence 
signals in immunofluorescence33,39,41. In this method, antibodies are first conjugate to 
single-stranded DNA (ssDNA) and then applied to immunostaining. The target proteins 
are revealed by fluorescent-labeled oligonucleotides through hybridization. The signal is 
removed by the DNA strand displacement reaction to allow reiterative 
immunofluorescence assays. It is proved that at least two sequential cycles can be 
performed with this method. However, this method suffers from non-specific 
hybridization of ssDNAs and non-specific binding between ssDNAs and endogenous 
biomolecules in the cells. Therefore, the signal-to-background ratio is compromised and 
the multiplexity is limited.  
1.4.3 Signal removal by chemical bleaching 
A cyanine-based fluorophore deactivation solution38 has been developed using alkaline 
oxidation chemistry. After 15 min of incubation, this fluorophore inactivation solution 
can quench over 98% of the signal intensity of cy3 and cy5. A similar method37 has been 
developed which oxidize the fluorophores using hydrogen peroxide in a condition of high 
pH and light. Compared to the cyanine-based fluorophore deactivation solution 
mentioned above, this method has a wide choice of fluorophores because it is compatible 
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with Alexa Fluor dyes. Within 30 to 45 min, a base-H2O2 solution is able to reduce the 
signal to the pre-staining level. Nonetheless, in both methods, the harsh chemical 
bleaching process may damage the epitopes of protein targets. As cycle number 
increases, the damage will be accumulated thus the quantification of proteins would be 
less accurate. Therefore, the cycle number is limited.  
1.4.4 CODEX multiplexed imaging 
 Recently, a new proteomics method, co-detection by indexing (CODEX) was developed 
by the Nolan lab40. The cells are first incubated with oligonucleotides conjugated 
antibodies. Each antibody carries a 5’ overhung DNA tag that enables stepwise 
polymerization-driven incorporation. In each cycle, two proteins are revealed by cyanine 
dye-labeled deoxynucleotides through incorporation reaction. The proteins are imaged by 
standard fluorescent microscope, then the fluorophores are removed by TCEP, allow 
other target proteins to be detected in later cycles. Through a deliberate design of the 
sequences of the DNA tags conjugated to the proteins, this method demonstrates the 
ability to quantify 30 proteins in the same sets of the cells. Compare to other methods 
mentioned above, which allows the detection of up to 4 proteins in parallel in each cycle, 
this approach can only quantify two target proteins each. It takes CODEX almost double 
of the cycle number to achieve the same multiplexity. However, due to the possible 
mismatch of the nucleotides to the DNA tags during the incorporation reactions, the 
results tend to be error-prone. The accumulated mismatches will keep reducing the 
detection accuracy as cycle number increases.  
1.5 Data analysis 
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Recent advances in single cell genomic and proteomic technologies have revolutionized 
the cell researches in an unprecedented way. Such technologies bring new insight into 
signaling pathways, biomarkers identification, rare cell populations identifications. These 
methods enable the definition of every single cell in a high dimensional manner. For 
example, the features of every single cell can be captured by the expression level of 
RNAs or proteins. While these technologies enable the extraction of high content single 
cell data, they bring new challenges to analyze and interpret the data.  
 Flow cytometry typically analyzes more than 10 protein targets in single cells42. 
Conventionally, a scatter plot is used to visualize the expression levels of two proteins at 
one time. To define the cell phenotypes or select cell groups of interest, a common 
method is called “manual gating”. The researchers need to manually define the boundary 
between cell groups in a biaxial plot of two parameters. It requires n(n-1)/2 scatter plots 
to get a full insight of an n-dimensional data set. This process is labor-intensive and time-
consuming, also it requires extensive knowledge of the cell subtypes and will cause huge 
variations by different researchers. Therefore, new models need to be developed to 
facilitate the analysis and interpretation of high content cellular data. 
To avoid the cumbersome step of manual gating, P. Qiu et al developed spanning-tree 
progression analysis of density-normalized events (SPADE)43. SPADE facilitates the 
visualization of high-dimensional cellular data in a two-dimensional space, also enables 
to capture the phenotypes in an unsupervised manner. SPADE algorithm arranges all the 
cells in a two-dimensional tree-shape graph with different branches. Each branch is 
composed of multiple nodes connected with each other. Each node represents a group of 
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cells which have similar expression level pattern of the analyzed proteins. In SPADE-
derived tree, each phenotype occupies one branch. Without manual gating, SPADE 
clustered cells into different phenotypes automatically. SPADE has been applied widely 
such as tumor tissue sdudies30, human natural killer cell diversity44. However, SPADE 
evaluates the data of each “node”, which are the average of a group of cells, thus it loses 
single-cell resolution.  
To visualize high-dimensional single cell data in two-dimensional space, dimensionality 
reduction methods are needed. Principal component analysis (PCA) has been applied in 
mass cytometry data sets27 and SCBC data sets23. However, PCA is based on linear 
transformation thus cannot represent the non-linear feature of many single-cell data sets. 
To address this issue, E. D. Amir et al developed viSNE45, a dimensionality reduction 
and visualization tool based on t-Distributed Stochastic Neighbor Embedding (t-SNE) 
algorithm46. viSNE projects high dimensional single cell data into a two-dimensional 
space while retains their local and global geometry. viSNE provides a scatter plot, which 
is called viSNE map, with every single cell shown as a single dot. In a viSNE map, cells 
of different phenotypes are separated into spatially distinct clusters. ViSNE has been 
applied extensively in single cell data analysis. For example, single-cell transcriptomics 
in embryo stem cells47, murine myeloid cell systems48, cell differentiation49… However, 
manual gating still needs to be involved in a viSNE map and the cell subpopulations are 
not always visually distinct. A potential solution could be a combination of viSNE with 
clustering method such as k-means, but k-means requires the predefinition of the number 
of clusters, which is not always clear. 
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To robustly reveal cell phenotypes in high-dimensional single cell data, J. H. Levine et al 
developed PhenoGraph50. In PhenoGraph, cells in a high-dimensional space are first 
connected to its nearest neighbors. Then the cells which are highly interconnected are 
clustered together in a density-based way. This method allows capturing cell phenotypes 
without predefinition of the number of cell clusters. With the combination of viSNE and 
PhenoGraph, cell phenotypes from high dimensional data set can be visualized51.  
1.6 Biomedical applications 
The advances of single-cell proteomics and novel data analysis algorithms have emerged 
to be powerful tools to reveal many biological mysteries in a systematic manner. One 
major application of novel single-cell proteomics is to define cell subpopulations. With 
conventional methods, cell subpopulations are defined by specific biomarkers, it needs 
extensive study to screen effective biomarkers. Additionally, these markers are typically 
screened by average results of cell populations, which will miss rare cell subtypes. Novel 
single-cell proteomics techniques, together with clustering algorithm43,45,50, allows to 
visualize single cells in a systematic way and distinguish the cell subpopulations in an 
unsupervised way. Additionally, such studies allow the discoveries of new biomarkers 
and rare cell subtypes43. Another exciting application is to study intracellular signaling 
networks. Protein-protein interactions are typically studied by gene knockout, small 
molecule inhibitors, RNA interference, etc. These studies are tedious and with low 
efficiency. What’s more important, human interference may change the cell behaviors, 
thus the results cannot represent the real situation. Single cell proteomics technologies 
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enable the protein-protein correlation studies, which can tell us the activation or 
inhibition relationships between proteins in their natural conditions. 
Single cell proteomics techniques have been utilized extensively in normal physiology 
and disease pathogenesis. For example, SCBC has been applied to cancer research52, 
cytokine profiling of immune cells53 and immune responses23. Single-cell mass cytometry 
has been utilized to study neuroinflammation and neurodegeneration54, human dendritic 
cell phenotypes55 and myogenic lineage mapping56. Cyclic immunofluorescence has also 
been used to reveal cell subtypes in tumor and brain tissues34–36,38,57–60.  
1.7 Summary and future perspectives 
The last decade witnessed fast development in single-cell proteomics technologies. I 
reviewed some of the major breakthroughs in this field above. Each method has its own 
unique advantages and drawbacks. For example, mass cytometry has the highest 
throughput among all the methods so far. Mass cytometry imaging and cyclic 
immunofluorescence enable the characterization of proteins in their natural context. 
SCBC can be applied to analyze secreted proteins. Researchers could choose the methods 
based on their specific requirements. It’s worth mention that the methods can be 
combined to avoid the shortcomings. For example, after SCBC, the cells could be 
recovered and subject to mass cytometry or cyclic immunofluorescence, thus secreted 
proteins, membrane proteins and cytoplasmic protein can all be quantified. These 
methods together have become powerful platforms to address many biological problems 
which cannot be solved by conventional bulk cell assays. 
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It is estimated that human proteome is comprised of 10,000 to several billions of different 
protein species61. Current proteomics methods allow the quantification of dozens of 
proteins in parallel, which only represents small fractions of the human proteome. One 
challenge is to further improve the multiplexity. A potential solution is to combine 
proteomics62,63 methods with genomics64, transcriptomics65,66 and metabolomics67,68 
methods. On the one hand, the results from other “omics” methods can provide hints of 
cell types and pathways and guide to identify proteins of interest. On the other hand, cells 
after proteomics assay and data analysis, the cell subtypes of interest can be isolated by 
microfluidics or microdissection and be subject to other “omics” techniques.  
The data from single cell proteomics assays are normally high dimensional data of a large 
number of cells, thus the analysis and interpretation could be challenging. To accurately 
quantify the protein expression levels, the first requirement is an accurate cell 
segmentation. In a typical tissue section, the nucleus could be missing and the cell 
morphology could be varied due to different cell types. One possible solution would be 
artificial intelligence algorithms, which has been studied extensively in imaging analysis. 
Second, most of the current data analysis is based on the protein expression level of 
single cells, which treats each cell as an isolated object. These results ignore the 
microenvironment and cell-to-cell interactions. New algorithm should incorporate the 
protein expression information and their coordination information. These results will 
advance our understanding of pathogenesis. For example, the abnormal region in a tissue 
could be identified, and their interactions with immune cells could be studied.  
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We expect exciting development and new technologies will appear in single-cell 
proteomics. These technologies will accelerate our understanding of many biological 
mysteries. Additionally, they will be widely applied in clinical diagnosis and 
personalized medicine.  For example, cytokine profiling in immune cells from blood 
samples can be applied in early diagnosis and used to provide personalized healthy 
suggestions. Tumor cell heterogeneity studies can be used in precision medicine. Single 
cell proteomics, together with other “omics” techniques, will boost the research in human 
health, revolutionize the clinical diagnosis and personalized medicine. 
1.8 Figures 
 
Figure 1.8.1.  (A) Image of an SCBC, flow is shown in blue and control channels are 
shown in red. (B) Image of the microchambers and the fluorescence barcode readouts. 
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The number of the cells in the chamber are shown in yellow. (C) The secreted proteins 
are detected by DEAL barcode arrays. Reproduced from Ref20 with permission from 
Springer Nature. 
 
 
Figure 1.8.2. Workflow of mass cytometry. Cells are first incubated with a mixture of 
elemental isotope labeled antibodies corresponding to the proteins of interest. Then the 
cells are nebulized into single-cell droplets. The elemental mass spectrum of each cell 
is detected by an inductively coupled plasma (ICP) time-of-flight (TOF) mass 
spectrometer. Reproduced from Ref28 with permission from Springer Nature. 
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CHAPTER 2 
HIGHLY MULTIPLEXED SINGLE CELL IN SITU PROTEIN ANALYSIS WITH 
CLEAVABLE FLUORESCENT ANTIBODIES 
2.1 Abstract 
The ability to obtain highly multiplexed protein measurements is crucial to facilitate 
scientific discoveries of normal physiology and disease pathogenesis. Here we describe 
an approach that enables highly multiplexed in situ protein analysis with cleavable 
fluorescent antibodies (CFAs). In this approach, fluorophores are first conjugated to an 
azide-based cleavable linker. By labeling antibodies with linker conjugated fluorophores, 
CFAs are synthesized. CFAs are applied in detection of target proteins by 
immunofluorescence. After each cycle of staining and imaging, the fluorescent signal can 
be removed with TCEP within 30 min. By reiterative staining, a highly multiplexed 
single cell in situ protein profiling can be achieved. We demonstrate the feasibility of this 
approach to quantify >100 protein targets in the same sets of cells. This approach has 
enormous potential for system biology, disease studies, and therapeutics development. 
2.2 Introduction 
Global measurements of different molecular species from single cells have the potential 
to reveal cell-to-cell variations, which are precluded by population-based 
measurements1,2. Various methods3–9 have been developed in the highly multiplexed 
nucleic acid analysis. An increasing percentage of researches have been focused on 
proteins, for its central roles in biological processes. Mass spectrometry-10 and 
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microarray-11 based protein profiling methods are powerful platforms for global analysis 
of proteins. However, these methods provide the results based on the average of cell 
populations. Fluorescence microscopy has been used extensively in protein analysis in 
single cells. However, the multiplex capacity is typically limited due to spectral overlap 
of commonly available organic fluorophores12–14. 
The recent development of technologies enables multiplexed protein analysis in single 
cells. Single cell barcode chips15–17 allow the analysis of secreted protein in single cells. 
However, this approach fails in quantifying cytoplasmic and membrane proteins in situ. 
Mass spectrometry-based methods enable highly multiplexed protein profiling in single 
cells. Nonetheless, mass cytometry18 cannot retain the location information of proteins. 
Mass cytometry imaging19,20 and ion beam imaging have limited imaging speed, thus the 
sample throughput is compromised. The concept of cyclic immunofluorescence has been 
applied in several technologies. In these approaches, photobleaching21, chemical 
bleaching22,23 or DNA strand displacement24,25 are used to remove fluorescent signal 
between cycles. While these methods allow quantification of multiplexed protein targets 
in single cells in situ, there are some drawbacks. Photobleaching is time-consuming and 
might cause photodamage, chemical bleaching might lead to the degradation of the 
biological samples, DNA strand displacement often suffers from mis-hybridization and 
non-specific binding.  
Here we describe a highly multiplexed single cell protein profiling method using 
cleavable fluorescent antibodies (CFAs). An azide-based linker is first conjugated to 
fluorophores. The cleavable fluorophores are then used to label antibodies. This method 
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achieves multiplexed protein analysis by reiterative cycles of immunostaining (Figure 
2.4.1). Each immunofluorescence cycle contains three major steps. First, protein targets 
are labeled by their corresponding antibodies tethered with spectral distinct cleavable 
fluorophores. Second, cells are imaged under the fluorescence microscope, the images are 
captured in each channel and can be decoded as quantitative protein expression profiles. 
In the third step, all the fluorophores are removed simultaneously by the cleavage of the 
linkers, which allow the staining and visualizing of other protein targets in the next cycle. 
Through reiterative cycles of immunostaining, fluorescent imaging, and signal removal, 
this method allows highly multiplexed in situ protein analysis in single cells. We 
demonstrate this method has the potential to quantify more than 100 protein targets in the 
same sets of cells. 
2.3 Results and discussion 
An azide-based linker has been reported that can be efficiently cleaved with mild 
reducing reagent tris(2-carboxyethyl)phosphine (TCEP)26. However, this linker requires a 
cleavage temperature at 65 oC, which might cause the degradation of biological samples 
after repeated TCEP treatment. Furthermore, the size of the linker is relatively large 
which might affect the specificity and affinity of antibodies to their target proteins. To 
overcome these limitations, we modified the previous azide-based cleavable linker and 
design a new one (Figure 2.4.2). The -CH2OAr group of the existing linker is substituted 
by a stronger electron donating group -CH2CH2R. This modification decreases the 
stability of the cleavage intermediate ROCH(NH2)R’ (Figure 2.4.3) and facilitates the 
cleavage to be at a lower temperature and higher rate (Figure 2.4.4). Additionally, the 
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size of the new linker is much smaller than the previously reported one so it’s more likely 
to maintain the binding affinity and specificity of the antibodies.  
We coupled the novel designed azide-based linker with fluorescein (Scheme 2.5.1), 
carboxytetramethylrhodamine (TAMRA) (Scheme 2.5.2), and Cy5 N-
hydroxysuccinimide (NHS) ester (Scheme 2.5.3). The products are further converted to 
NHS esters. The antibodies are labeled through the NHS ester reaction between the 
cleavable fluorophores and the lysine residues (Figure 2.4.2B).  
To achieve an optimized cleavage efficiency, we studied the cleavage at different TCEP 
concentration (Figure 2.4.5), pH values (Figure 2.4.6), and reaction times (Figure 2.4.7). 
We find the maximum cleavage efficiency can be achieved in TCEP concentration of 100 
mM, pH 9.5, and reaction time of 30 min. We applied CFAs in immunofluorescence to 
demonstrate their feasibility in single cell protein analysis. We stained Ki67 with Ab-N3-
Fluorescein (Figure 2.4.8A), α-tubulin with Ab-N3-TAMRA (Figure 2.4.8D), and Ki67 
with Ab-N3-Cy5 (Figure 2.4.8G). To study whether the binding affinity and specificity 
are retained by CFAs, we did control experiment by staining Ki67 and α-tubulin with 
conventional fluorescent antibodies (Figure 2.4.9). The spatial distribution of proteins 
and the expression levels revealed by conventional fluorescent antibodies are highly 
comparable with those by CFAs. We applied the optimized cleavage condition and a 
cleavage efficiency of >95% was achieved in the cells stained by CFA (Figure 2.4.8). In 
the control experiments, the fluorescence intensities are largely maintained after 
treatment with TCEP at the optimized condition, with a signal loss of less than 30% 
(Figure 2.4.9). These results demonstrate that CFAs can preserve the binding affinity and 
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specificity, and the fluorophores can be efficiently removed after cell staining. CFAs 
make promising tools in multiplexed single cell protein analysis.  
Most of the antibodies applied in immunofluorescence recognize continuous linear 
epitopes27 which determined by the primary amino acid sequences in the target proteins. 
Since TCEP treatment does not alter the structures or amino acid sequences, we expect 
the antigenicity of epitopes can be preserved after TCEP treatment. To validate our 
hypothesis, we incubated Hela cells with TCEP for 24 hours, then stained α-tubulin with 
Ab-N3-TAMRA (Figure 2.4.8J). The protein spatial distributions and expression levels 
highly resemble the result from control experiments (Figure 2.4.8K), which no TCEP 
treatment was applied and the cells are stained with conventional fluorescent antibodies. 
These results indicate that TCEP preserves the antigenicity of target proteins while 
removing the fluorescent signal.  
To demonstrate the feasibility of this approach in multicycle immunostaining, we stained 
one protein per cycle with its corresponding N3-TAMRA labeled primary antibody. 
Through 12 cycles of staining, imaging, and cleavage, p-4E-BP1, pan cytokeratin, p-Akt 
(T308), p-Akt (S473), p-p44/42 MAPK, EGF receptor, c-erbB2, p53, Ki67, Ezh2, 
vimentin, and histone H4 were located and visualized in the same set of cells (Figure 
2.4.10). In the control experiments, we labeled these 12 proteins with TAMRA 
conjugated primary antibodies in different sets of cells (Figure 2.4.11). The spatial 
distribution of proteins resulted from CFA-based approach and conventional 
immunofluorescence are highly comparable with each other. To validate the quantitative 
power of our approach, we compared the mean expression level per cell characterized by 
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CFA-based approach and the conventional immunofluorescence. The expression levels of 
different proteins are quantitated by fluorescence intensities. For all proteins with 
expression level distributed in a wide dynamic range, these two methods show a high 
consistency with respect to mean values and standard deviations (Figure 2.4.12A). 
Correlation between results from these two methods has an R2 value of 0.96 and a slope 
of 1.11 (Figure 2.4.12B). These results indicate CFA-based method has high multicycle 
potential and quantitative ability. With 3 to 4 proteins detected by different fluorophores 
in each cycle, a comprehensive protein analysis could be achieved.  
Cell nuclei were stained with DAPI and imaged together in each cycle with proteins. The 
DAPI image in each cycle provided fiducial points to align and overlay the images taken 
from consecutive immunofluorescence cycles (Figure 2.4.10M). By doing this, we can 
study the colocalization of different proteins within the resolution of the fluorescence 
microscope (~300 nm). To test the accuracy of the alignment, we stained Ki67 with Ab-
N3-TAMRA in two continuous immunofluorescence cycles. By using DAPI to align and 
overlay the images, the Ki67 stained in two cycles exactly matched each other (Figure 
2.4.13). This result indicates CFA-based methods can be used to study protein 
colocalization at the pixel level.  
With multiplexed single cell protein analysis results, we extracted the expression level 
information of each protein for every single cell. The expression level of all 12 proteins 
are widely distributed across a wide dynamic range, reveals the heterogeneity of 
genetically identical Hela cells (Figure 2.4.14A). The expression levels for almost all the 
proteins follow a right-skewed distribution with a long tail, which implies the generation 
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of the proteins is in a translational burst, rather than constant rates28.  We study the 
correlation between each protein pair, calculated the corresponding correlation coefficient 
(Figure 2.4.14B). Applying a hierarchical clustering algorithm, a group of proteins which 
are highly correlated with each other is identified. All the protein belonged to the 
identified group are involved in ERBB receptor signaling29 and cell proliferation-related 
pathways30,31. 
In summary, we have developed and azide-based linker and successfully tethered it to 
different fluorophores. The linker can be efficiently removed with 30 min at normal 
human body temperature. We used the cleavable fluorophores to label antibodies and 
demonstrated its feasibility in multiplexed single cell protein analysis. The multiplexity 
of this approach is determined by the number of proteins quantified in each cycle and the 
number of cycles. By using spectral distinct fluorophores, 4 to 5 proteins can be detected 
simultaneously in the same cycle. We demonstrated the preservation of antigenicity after 
a 24-h TCEP treatment, which suggests the cycle number can be dramatically increased.  
Therefore, we anticipate CFA-based approach has the potential to detect more than 100 
protein targets in situ in the same set of cells. This method analyzes the protein targets in 
their natural context without disturbing other biomolecules, preserving the intactness of 
the biological sample. Therefore, it’s compatible with downstream analysis tools such as 
mass spectrometry, RNA seq et al. The concept can be applied to multiplexed nucleic 
acid in situ hybridization assay. These methods merged a comprehensive molecular 
imaging platform, which will enable the researchers to visualize the single cells in a 
brand-new perspective.  
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2.4 Figures 
 
Figure 2.4.1 Highly multiplexed single-cell in situ protein analysis with cleavable 
fluorescent antibodies. Antibodies are labeled with cleavable fluorophores and then 
applied in protein staining. After imaging, the cleavage of the linkers allows the 
removal of the fluorophores from the cells. Through reiterative cycles of staining, 
imaging, and cleavage, a large number of different protein targets can be detected in 
individual cells in situ.  
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Figure 2.4.2 A) Synthesis of the azide-based cleavable linker. Reagents and 
conditions: i) diethyl ether, 0 °C to RT, 30 min, 97%; ii) (CH3)3SiN3, SnCl4, CH2Cl2, 
78 °C to RT, 15 h, 44 %; iii) piperidine, CH2Cl2, RT, 30 min, 80 %. B) Structures of 
the cleavable fluorescent antibodies Ab-N3-Fluorescein, Ab-N3-TAMRA, and Ab-N3-
Cy5. 
 
 
Figure 2.4.3 Mechanisms of cleave of fluorophores from cleavable fluorescent 
antibodies. The azide group on the cleavable linker is reduced by TCEP via the 
Staudinger reaction. The following hydrolysis breaks the linker and separates the 
fluorophores and antibodies. 
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Figure 2.4.4 Cleavage reaction rate comparison between of the reported linker26 and 
the linker we designed. Representative absorption spectra of (A) cleavable Cy5 labeled 
antibody with the new linker, and its cleavage products generated by incubation with 
20 mM TCEP for (B) 15, (C) 30, (D) 45 and (E) 60 min. Representative absorption 
spectra of (F) cleavable Cy5 labeled antibody with the reported linker, and its cleavage 
products generated by incubation with 20 mM TCEP for (G) 15, (H) 30, (I) 45 and (J) 
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60 min. (K) The cleavage reaction efficiency of the cleavable Cy5 labeled antibodies 
with the two respective linkers for different reaction time. 
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Figure 2.4.5 (A) Vimentin is detected with Ab-N3-Cy5 and (B) the fluorophores are 
cleaved in 1 mM TCEP. (C) Fluorescence intensity profile corresponding to the red 
line and green line positions in (A) and (B). (D) Vimentin is detected with Ab-N3-Cy5 
and (E) and the fluorophores are cleaved 10 mM TCEP. (F) Fluorescence intensity 
profile corresponding to the positions indicated by red line in (D) and green line in (E). 
(G) Vimentin is detected with Ab-N3-Cy5 and (H) the fluorophores are cleaved in 100 
mM TCEP. (I) Fluorescence intensity profile corresponding to the positions indicated 
by red line in (G) and green line positions in (H). (J) Vimentin is detected with Ab-N3-
Cy5 and (K) the fluorophores are cleaved in 1 M TCEP. (L) Fluorescence intensity 
profile corresponding to the positions indicated by red line in (J) and green line in (K). 
(M) Fluorophore cleavage efficiency with TCEP at different concentrations (n = 30 
positions). Scale bars, 20 µm. 
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Figure 2.4.6. (A) Vimentin is detected with Ab-N3-Cy5 and (B) the fluorophores are 
cleaved with 100 mM TCEP (pH = 7.5). (C) Fluorescence intensity profile 
corresponding to the positions indicated by red line in (A) and green line positions in 
(B). (D) Vimentin is detected with Ab-N3-Cy5 and (E) the fluorophores are cleaved 
with 100 mM TCEP (pH = 8.5). (F) Fluorescence intensity profile corresponding to the 
positions indicated by red line in (D) and green line in (E). (G) Vimentin is detected 
with Ab-N3-Cy5 and (H) the fluorophores are cleaved in 100 mM TCEP (pH = 9.5). (I) 
Fluorescence intensity profile corresponding to the positions indicated by red line in 
(G) and green line in (H). (J) Vimentin is detected with Ab-N3-Cy5 and (K) the 
fluorophores are cleaved with 100 mM TCEP (pH = 10.5). (L) Fluorescence intensity 
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profile corresponding to the positions indicated by red line in (J) and green line in (K). 
(M) Fluorophore cleavage efficiency with 100 mM TCEP at different pH (n = 30 
positions). Scale bars, 20 µm. 
 
 
Figure 2.4.7. (A) Vimentin is detected with Ab-N3-Cy5 and (B) the fluorophores are 
cleaved by 100 mM TCEP (pH = 9.5) for 5 min. (C) Fluorescence intensity profile 
corresponding to the positions indicated by red line in (A) and green line in (B). (D) 
Vimentin is detected with Ab-N3-Cy5 and (E) the fluorophores are cleaved by 100 mM 
TCEP (pH = 9.5) for 15 min. (F) Fluorescence intensity profile corresponding to the 
positions indicated by red line in (D) and green line in (E). (G) Vimentin is detected 
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with Ab-N3-Cy5 and (H) the fluorophores are cleaved by100 mM TCEP (pH = 9.5) for 
30 min. (I) Fluorescence intensity profile corresponding to the positions indicated by 
red line in (G) and green line in (H). (J) Vimentin is detected with Ab-N3-Cy5 and (K) 
the fluorophores are cleaved by 100 mM TCEP (pH = 9.5) for 1 hr. (L) Fluorescence 
intensity profile corresponding to the positions indicated by red line in (J) and green 
line in (K). (M) Fluorophore cleavage efficiency with 100 mM TCEP (pH = 9.5) for 
different time (n = 30 positions). Scale bars, 20 µm. 
 
 
Figure 2.4.8. A) Ki67 is detected with Ab-N3-Fluorescein and B) followed by cleavage 
with TCEP. C) Fluorescence intensity profiles of the positions indicated by red line in 
(A) and green line in (B). D) α-Tubulin is detected with Ab-N3-TAMRA and E) 
followed by cleavage with TCEP. F) Fluorescence intensity profiles of the positions 
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indicated by red line in (D) and green line in (E). G) Ki67 is detected with Ab-N3-Cy5 
and followed by cleavage with TCEP. I) Fluorescence intensity profiles of the positions 
indicated by red line in (G) and green lines in (H). J) α-tubulin is detected with Ab-N3-
TAMRA after 24-hour TCEP treatment. K) α-tubulin is directly detected with Ab-N3-
TAMRA without TCEP treatment. L) Fluorescence intensity of the α-tubulin staining 
in (J) and (K) (n=30). Scale bars: 20 mm. 
 
 
Figure 2.4.9. (A) Ki67 is detected with Fluorescein conjugated antibodies and (B) 
followed by TCEP incubation. (C) Fluorescence intensity profile corresponding to the 
positions indicated by red line in (A) and green line in (B). (D) α-Tubulin is detected 
with TAMRA conjugated antibodies, and (E) followed by TCEP incubation. (F) 
Fluorescence intensity profile corresponding to the positions indicated by red line in 
(D) and green line in (E). (G) Ki67 is detected with Cy5 conjugated antibodies and (H) 
followed by TCEP incubation. (I) Fluorescence intensity profile corresponding to the 
positions indicated by red line in (G) and green line in (H). Scale bars, 20 µm. 
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Figure 2.4.10. A) p-4E-BP1, B) pan cytokeratin, C) p-Akt (T308), D) p-Akt (S473), E) 
p-p44/42 MAPK, F) EGF receptor, G) c-erbB2, H) p53, I) Ki67, J) Ezh2, K) vimentin, 
and L) histone H4 were detected with the corresponding Ab-N3-TAMRA in the same 
set of cells. M) Digital overlay of (A)–(L). Scale bars: 60 µm. 
 
 
Figure 2.4.11. (A) p-4E-BP1, (B) Pan Cytokeratin, (C) p-Akt (T308), (D) p-Akt 
(S473), (E) p-p44/42 MAPK, (F) EGF receptor, (G) c-erbB2, (H) p53, (I) Ki67, (J) 
Ezh2, (K) Vimentin and (L) Histone H4 are detected with TAMRA labeled antibodies 
in different cells. Scale bars, 60 µm. 
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Figure 2.4.12. (A) Mean expression level per cell (n = 30 cells) of 12 different proteins 
measured by immunofluorescence with CFA and conventional immunofluorescence. 
(B) Comparison of the results obtained by immunofluorescence with CFA and 
conventional immunofluorescence yields a R-square value of 0.96 and a slope of 1.11. 
 
 
Figure 2.4.13. Image alignment and overlay with DAPI-stained nuclei (blue) as 
fiducial points. (A) Ki67 is stained with Ab-N3-TAMRA (green) and (B) subsequently 
incubated with TCEP. (C) Ki67 is re-stained with Ab-N3-TAMRA (red). (D) Digital 
alignment and overlay of A and C. Scale bars, 3 µm. 
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Figure 2.4.14. Protein expression heterogeneity and correlation. (A) Histograms of the 
expression level per cell of all 12 proteins. (B) Correlation of the expression levels of 
the 12 measured proteins and the hierarchical clustering tree. The protein names are 
shown in the diagonal. The upper triangle shows correlation coefficient of each protein 
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pair. The colors in the lower triangle correspond to the correlation coefficient.  With 
hierarchical clustering, a group of proteins defined by a specific threshold on the 
cluster tree (dashed line) is indicated by the black box in the matrix and the red lines on 
the tree. 
 
2.5 Schemes 
 
Scheme 2.5.1. Synthesis of Ab-N3-Fluorescein. Reagents and conditions: (i) DMF/1 M 
NaHCO3, rt, 6 h. (ii) N, N'- disuccinimidyl carbonate, Et3N, DMF, rt, 10 h. (iii) 
antibodies, 0.1 M NaHCO3, rt, 15 min. 
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Scheme 2.5.2. Synthesis of Ab-N3-TAMRA. Reagents and conditions: (i) DMF/1 M 
NaHCO3, rt, 6 h. (ii) N, N'- disuccinimidyl carbonate, Et3N, DMF, rt, 10 h. (iii) 
antibodies, 0.1 M NaHCO3, rt, 15 min. 
 
 
Scheme 2.5.3. Synthesis of Ab-N3-Cy5. Reagents and conditions: (i) DMF/1 M 
NaHCO3, rt, 6 h. (ii) N, N'- disuccinimidyl carbonate, Et3N, DMF, rt, 10 h. (iii) 
antibodies, 0.1 M NaHCO3, rt, 15 min. 
 
2.6 Methods 
2.6.1 General Information 
Chemicals and solvents were purchased from Sigma-Aldrich or TCI America and were 
used directly without further purification, unless otherwise noted. Bioreagents were 
purchased from Invitrogen, unless otherwise indicated. 1H-NMR and 13C-NMR were 
taken on Varian Innova 400 MHz NMR spectrometers. Chemical shifts are reported in 
parts permillion (ppm) downfield from tetramethylsilane (TMS). Data are reported as 
follows: chemicalshift, multiplicity: singlet (s), doublet (d), triplet (t), multiplet (m), 
coupling constants J in Hz, and integration. HRMS was performed by the Arizona State 
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University mass spectrometry facility. Absorption spectra were obtained on a NanoVue 
Plus spectrometer. 
2.6.2 Synthesis of the azidoethyl linker 
(9H-fluoren-9-yl)methyl(2-(1,3-dioxolan-2-yl)ethyl)carbamate (1): A stirred solution 
of 9-fluorenylmethyl chloroformate (6.6 g; 25.6 mmol) in 40 ml of ether was first cooled 
in an ice bath. Commercially available 2-(aminoethyl)-1,3-dioxolane (2 g; 17.0 mmol) 
was slowly added. The reaction mixture was stirred at 0°C for 10 minutes, then at room 
temperature for 30 min. Subsequently, the ether was removed under reduced pressure. 
The residue was purified by flash column chromatography (ethyl acetate/hexane, 1:2 to 
1:1) to afford compound 1 as a white solid (5.67 g; 97% yield). 1H NMR (400 MHz, 
CDCl3) δ 7.75 (d, J = 7.5 Hz, 2H), 7.62 (d, J = 7.5 Hz, 2H), 7.39 (t, J = 7.5 Hz, 2H), 7.31 
(d, J = 7.5 Hz, 2H), 4.90 (t, J = 4.5 Hz, 1H), 4.41 (d, J = 7.1 Hz, 2H), 4.24 (t, J = 8 Hz, 
1H), 3.96-3.88 (m, 2H), 3.83-3.75 (m, 2H), 3.38 (t, J = 6.2 Hz, 2H), 1.93-1.88 (m, 2H); 
13C NMR (100 MHz, CDCl3) δ 156.43, 144.10, 141.31, 127.67, 127.05, 125.13, 119.99, 
103.31, 66.56, 64.88, 47.33, 36.40, 33.36; HRMS (ESI, m/z) calcd for C20H21NO4Na 
[(M+Na)+]: 362.1368, found: 362.1360. 
(9H-fluoren-9-yl)methyl(3-azido-3-(2-hydroxyethoxy)propyl)carbamate (2): The 
stirred solution of compound 1(1.0 g; 2.95 mmol) in 20 ml CH2Cl2 was first cooled at -
78 °C in a dry ice/acetone bath under nitrogen atmosphere. Then azidotrimethylsilane 
(0.8 ml; 6.11 mmol) and Tin (IV) chloride (1 M solution in CH2Cl2; 150 µl) were added. 
The reaction mixture was warmed to room temperature and stirred for over 15 hours. 
After the completion of the reaction, CH2Cl2 (100 ml) was added to the reaction mixture. 
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The organic layer was washed with water and dried over anhydrous Na2SO4. The CH2Cl2 
was removed under reduced pressure vacuum. The residue was purified by a flash 
column chromatography (ethyl acetate/hexane, 1:1) to afford compound 2 as a colorless 
liquid (495 mg; 44% yield). 1H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 7.5 Hz, 2H), 7.57 
(d, J = 7.4 Hz, 2H), 7.39 (td, J = 7.5, 1.1 Hz, 2H), 7.30 (td, J = 7.4, 1.2 Hz, 2H), 4.48 (t, J 
= 6 Hz, 1H), 4.43 (d, J = 4 Hz, 2H), 4.19 (t, J = 6.6 Hz, 1H), 3.91-3.87 (m, 1H), 3.78-3.69 
(m, 2H), 3.61- 3.56 (m, 1H), 3.49-3.40 (m, 1H), 3.29-3.20 (m, 1H), 1.95- 1.89 (m, 2H); 
13C NMR (100 MHz, CDCl3) δ 156.60, 143.87, 141.31, 127.68, 127.04, 124.93, 119.95, 
91.01, 70.74, 66.46, 61.53, 47.26, 36.88, 34.73; HRMS (APCI, m/z) calcd for 
C20H23N2O4 [(M-N2+H)+]: 355.1658, found: 355.1648. 
2-(3-amino-1-azidopropoxy)ethanol (3): To a stirred solution of compound 2 (300mg; 
0.79 mmol) in 3 ml CH2Cl2, piperidine (0.3 ml; 3.03 mmol) was added . The reaction 
mixture was stirred at room temperature for 30 minutes. The solvent and piperidine were 
dried under vacuum. The residue was purified by flash column chromatography (ethyl 
acetate/hexane, 1:1, then 5% NH4OH in methanol/dichloromethane, 1:1) to afford 
compound 3 as a brown oil (100 mg; 80% yield). 1H NMR (400 MHz, CD3OD) δ 4.66 (t, 
J = 5.9 Hz, 1H), 3.81-3.76 (m, 1H), 3.65- 3.52 (m, 3H), 2.81 (t, J = 6.7 Hz, 2H), 1.91-
1.86 (m, 2H); 13C NMR (100 MHz, CD3OD) δ 91.28, 70.50, 60.50, 36.55, 35.27; HRMS 
(FAB, m/z) calcd for C5H13N4O2 [(M+H)+]: 161.1038, found: 161.1037. 
2.6.2 Synthesis of cleavable fluorescent antibodies 
Synthesis of Ab-N3-Fluorescein 
N3-Fluorescein (4): To a stirred solution of compound 3 (1 mg; 6.24 µmol) in anhydrous 
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DMF (860 µl), 1 M NaHCO3 (100 µl) was added. The solution was stirred at room 
temperature for 5 minutes, then fluorescein NHS (N-hydroxysuccinimide) ester (1 mg; 
2.11 µmol) in 40 µl of anhydrous DMF was added. The reaction was performed at room 
temperature for 6 hours. DMF was removed completely under high pressure vacuum after 
the completion of the reaction. The crude product was purified by a preparative silica gel 
TLC plate (CH3OH/CH2Cl2, 1:5) to afford 4 as a yellow solid. 1H NMR (400 MHz, 
CD3OD) δ 8.09-7.99 (m, 2H), 7.25 (d, J = 8 Hz, 1H), 6.76-6.68 (m, 2H), 6.62 (t, J = 1.9 
Hz, 2H), 6.53-6.47 (m, 2H), 4.66 (t, J = 6 Hz, 1H), 3.86-3.79 (m, 1H), 3.69-3.65 (m, 2H), 
3.54-3.50 (m, 1H), 3.59-3.55 (m, 2H), 2.02 (q, J = 6.5 Hz, 2H); HRMS (APCI, m/z) calcd 
for C26H23N4O8 [(M+H)+]: 519.1516, found: 519.1518. 
N3-Fluorescein NHS ester (5): To a stirred solution of compound 4 in anhydrous DMF 
(400 µl), DSC (N, N'-disuccinimidyl carbonate) (2 mg; 7.8 µmol) and triethylamine (1.1 
µl; 7.9 µmol) were added. The reaction mixture was stirred for 10 hours. DMF was 
removed under vacuum after the completion of the reaction. 30 ml of ethyl acetate was 
added to the reaction mixture. The organic layer was washed with water, then dried over 
anhydrous Na2SO4 and evaporated under vacuum to afford compound 5 as a yellow solid. 
The product is ready to be used in antibody labeling. 
Ab-N3-Fluorescein (6): Antibodies (1mg/ml) were dissolved in 1× phosphate buffered 
saline (pH = 7.4) and compound 5 was dissolved in anhydrous DMF (500 µl). Sodium 
bicarbonate aqueous solution (1M, 2 µl) and compound 5 (1 µl) were then added to the 
antibody solution (20 µl). The reaction mixture was incubated at room temperature for 15 
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min. Lastly, the N3-Fluorescein coupled antibodies were purified by size exclusion 
chromatography using Bio-Gel P-6 (Bio-Rad Laboratories). 
2.6.3 Synthesis of Ab-N3-TAMRA 
N3-TAMRA (7): The preparation procedure was similar as the synthesis of compound 4. 
The crude product was purified by a preparative silica gel TLC plate (CH3OH/CH2Cl2, 
1:2) to afford 7 as a red solid. 1H NMR (400 MHz, CD3OD) δ 8.50 (s, 1H), 8.06 (d, J = 6 
Hz, 1H), 7.36 (d, J = 8 Hz, 1H), 7.25 (d, J = 9.5 Hz, 2H), 7.02 (dd, J = 9.5, 2.4 Hz, 2H), 
6.93 (d, J = 2.4 Hz, 2H), 4.75 (t, J = 6 Hz, 1H), 3.92- 3.89 (m, 2H), 3.76 (t, J = 4.7 Hz, 
2H), 3.28 (s, 12H), 3.13 (t, J = 6.7 Hz, 2H), 2.16- 2.08 (m, 2H); HRMS (APCI, m/z) 
calcd for C30H33N6O6 [(M+H)+]: 573.2462, found: 573.2456. 
N3-TAMRA NHS ester (8): The preparation procedure was similar to the synthesis of 
compound 5. After adding 30 ml of CH2Cl2, the organic layer was washed with water, 
dried over anhydrous Na2SO4 and evaporated under vacuum to afford compound 8 as a 
red solid. The product is ready to be used in antibody labeling. 
Ab-N3-TAMRA (9): The preparation procedure was similar as the synthesis of Ab-N3- 
Fluorescein.  
2.6.4 Synthesis of Ab-N3-Cy5 
N3-Cy5 (10): The preparation procedure was similar as the synthesis of compound 4. The 
crude product was purified by a preparative silica gel TLC plate (CH3OH/CH2Cl2, 1:3) to 
afford 10 as a blue solid. 1H NMR (400 MHz, CD3OD) δ 8.31-8.23 (m, 2H), 7.93 (s, 1H), 
7.84 (dd, J = 8.2, 3.6 Hz, 3H), 7.29 (dd, J = 8.3, 5.8 Hz, 2H), 6.63 (t, J = 12.4 Hz, 1H), 
6.29 (dd, J = 13.7, 8.5 Hz, 2H), 4.54 (t, J = 6.0 Hz, 1H), 4.19-4.06 (m, 5H), 3.79 (dt, J = 
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10.2, 4.3 Hz, 1H), 3.65 (dd, J = 5.3, 4.2 Hz, 2H), 3.59-3.53 (m, 1H), 2.15 (t, J = 7.2 Hz, 
2H), 1.86-1.76 (m, 4H), 1.66-1.61 (m, 3H), 1.42-1.24 (m, 12H), 0.92-0.83 (m, 5H); 
HRMS (ESI-, m/z) calcd for C38H49N6O9S2 [(M)-]: 797.3002, found: 797.3001. 
N3-Cy5 NHS ester (11): The preparation procedure was similar as the synthesis of 
compound 5. The crude product was purified by a preparative silica gel TLC plate (4% 
acetic acid in ethyl acetate) to afford 11 as a blue solid. The product is ready to be used in 
antibody labeling. 
Ab-N3-Cy5 (12): The preparation procedure was similar as the synthesis of Ab-N3- 
Fluorescein. 
2.6.5 Fluorophore cleavage in cells 
Cell culture 
HeLa CCL-2 cells (ATCC) were maintained in Dulbelcco’s modified Eagle’s Medium 
(DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 g/mL 
streptomycin in a humidified atmosphere at 37 °C with 5% CO2. Cells were plated on 
chambered coverglass (0.2 ml medium/chamber) (Thermo Scientific) and allowed to 
reach 60% confluency in 1-2 days. 
Cell fixation 
Cultured HeLa CCL-2 cells were first fixed with 4% formaldehyde at 37 °C for 15 min, 
then permeabilized with 0.2% (vol/vol) Triton X-100 at room temperature for 15 min. 
Subsequently, the cells were blocked in 1X blocking buffer (1% (wt/vol) bovine serum 
albumin, 0.1% (vol/vol) Triton X-100, 10% (vol/vol) normal goat serum) at room 
temperature for 1 h. 
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Labeling of vimentin and fluorophore cleavage under different conditions 
Fixed and blocked HeLa CCL-2 cells were first incubated with chicken anti-vimentin (5 
µg/mL, Abcam) at room temperature for 1 h, then in N3-Cy5 conjugated goat anti-
chicken IgG (10 µg/mL) at room temperature for 1 h. The stained cells were rinsed with 
GLOX buffer (0.4% glucose and 10mM Tris HCl in 2× saline sodium citrate buffer (300 
mM sodium chloride, 30 mM trisodium citrate, pH = 7.0)), and imaged in GLOX 
solution (0.37 mg/mL glucose oxidase, 1% catalase in GLOX buffer). To test the 
cleavage efficiency with different TCEP concentration, the cells were incubated with 1, 
10, 100 or 1000 mM TCEP (pH = 9.5) at 37 °C for 30 minutes (Figure 2.4.5). To test the 
cleavage under different pH, the cells were incubated with 100 mM TCEP (pH = 7.5, 8.5, 
9.5 or 10.5) at 37 °C for 30 minutes (Figure 2.4.6). To test the efficiency of different 
incubation time, the cells were incubated with TCEP (100 mM, pH = 9.5) at 37 °C for 5, 
15, 30 or 60 minutes (Figure 2.4.7). After fluorophore cleavage, the cells were rinsed 
with GLOX buffer and imaged in GLOX solution. 
Labeling of Ki67 and fluorophore cleavage 
Fixed and blocked HeLa CCL-2 cells were incubated with rabbit anti-Ki67 (5 µg/mL, 
Fisher 
Scientific) at room temperature for 1 h, and then with 10 µg/mL N3-Fluorescein (Figure 
2.4.8A), N3-Cy5 (Figure 2.4.8G), conventional Fluorescein (Figure 2.4.9A) or 
conventional Cy5 (Figure 2.4.9G) conjugated goat anti-rabbit IgG at room temperature 
for 1 h. The stained cells were imaged in GLOX solution. Cleavage was done by 
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incubating the cells with TCEP (100mM, pH = 9.5) at 37 °C for 30 minutes, and then 
imaged again in GLOX solution. 
Labeling of α-tubulin and fluorophore cleavage 
Fixed and blocked HeLa CCL-2 cells were incubated with 100 mM TCEP (Figure 2.4.8J) 
or PBS (Figure 2.4.8K) at 37 °C for 24 hours. The cells were incubated with rat anti-α-
tubulin (5 µg/mL, Novus) at room temperature for 1 h, then with N3-TAMRA (10 µg/mL, 
Figure 2.4.8D) or conventional TAMRA (Figure 2.4.9D) conjugated goat anti-rat IgG at 
room temperature for 1 h. The stained cells were imaged in 2× saline-sodium citrate 
buffer. In the cleavage step, cells were incubated with 100 mM TCEP at 37°C for 30 
minutes, followed by another imaging step. 
2.6.6 Multiplexed protein analysis with CFA 
Fixed and blocked HeLa CCL-2 cells were incubated with Ab-N3-TAMRA (primary 
antibodies) at a concentration of 5 µg/mL at room temperature for 1 h. The cells were 
imaged in 2× saline sodium citrate buffer. The cleavage was performed by treating the 
cells with 100 mM TCEP (pH = 9.5) at 37 °C for 30 minutes. The next 
immunofluorescence cycle was performed after cleavage. Rabbit anti-p-4E-BP1 (Cell 
Signaling), mouse anti-Pan Cytokeratin (Sigma), rabbit anti-p-Akt (T308) (Cell 
Signaling), rabbit anti-p-Akt (S473) (Cell Signaling), rabbit anti-p-p44/42 MAPK (Cell 
Signaling), rabbit anti-EGF receptor (Cell Signaling), rabbit anti-c-erbB-2 (Fisher 
Scientific), rabbit anti-p53 (Cell Signaling), rabbit anti-Ki67 (Fisher Scientific), rabbit 
anti-Ezh2 (Cell Signaling), chicken anti-Vimentin (Jackson Laboratory) and rabbit anti-
Histone H4 (Abcam) were used in the consecutive immunofluorescence cycles. To stain 
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Ki67 in two continuous immunofluorescence cycles, fixed and blocked HeLa CCL-2 
cells were first incubated with rabbit anti-Ki67 (5 µg/mL) labeled with N3-TAMRA at 
room temperature for 1 h. The stained cells were then imaged in 2× saline-sodium citrate 
buffer, followed by cleavage in 100 mM TCEP (pH = 9.5) at 37 °C for 30 minutes. 
Subsequently, the cells were again incubated with N3-TAMRA conjugated rabbit anti-
Ki67 (5 µg/m) at room temperature for 1 h, then imaged in 2× saline-sodium citrate 
buffer. In the control experiment, fixed and blocked HeLa CCL-2 cells were incubated 
with TAMRA labeled primary antibodies (5 µg/mL) at room temperature for 1 h. 
2.6.7 Imaging and data analysis 
A Nikon Ti-E epifluorescence microscope was used in imaging. The stained cells were 
imaged under 40× objective. A CoolSNAP HQ2 camera was used to capture cell images. 
The images were processed and analyzed with NIS-Elements Imaging software. Chroma 
filter 49011 was used for Fluorescein and Alexa 488. Chroma filters 49004 and 49009 
were used for TAMRA and Cy5, respectively. Images were aligned with NIS-Elements 
and overlaid with ImageJ. Microsoft Excel was used to generate protein expression 
heterogeneity and correlation graphs. The hierarchical clustering was analyzed with 
Cluster 3.0 (http://bonsai.hgc.jp/~mdehoon/software/cluster/). 
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CHAPTER 3 
HIGHLY SENSITIVE AND MULTIPLEXED IN SITU PROTEIN PROFILING WITH 
CLEAVABLE FLUORESCENT TYRAMIDE 
3.1 Abstract 
The ability to comprehensively profile proteins with a wide range of abundances in single 
cells in situ is crucial for our understanding of health and disease. Here we present a 
highly sensitive and multiplexed in situ protein analysis approach using cleavable 
fluorescent tyramide (CFT). In this method, horseradish peroxidase (HRP) conjugated 
antibodies are applied to recognize their target proteins and catalyze the enzymatic 
deposition of CFT. After fluorescence imaging, the deposited fluorophores are efficiently 
cleaved, while HRP is deactivated simultaneously. Through reiterative staining cycles, 
this approach has the potential to sensitively detect >50 different proteins in intact tissues 
at the optical resolution. This comprehensive in situ protein profiling technology will 
bring new insights into systems biology, molecular diagnosis and cellular targeted 
therapies.  
 3.2 Introduction 
Comprehensive protein profiling in individual cells of intact tissues in situ holds great 
promise to unlock major mysteries in neuroscience, cancer and stem cell biology1 since it 
can reveal the spatial organization, gene expression regulation, and interactions of the 
diverse cell types in complex multicellular organisms. However, due to the spectral 
overlap of commonly available organic fluorophores,2–4 conventional protein imaging 
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technologies, such as immunohistochemistry (IHC) and immunofluorescence (IF), only 
allow a handful of proteins to be detected in one tissue sample. 
Recently, a number of methods have been explored to enable multiplexed in situ protein 
analysis.5–13 Nonetheless, with the detection tags directly conjugated to antibodies, the 
existing methods have low detection sensitivity. This limitation hinders their applications 
to study proteins with low expression levels, especially for protein profiling in highly 
autofluorescent tissues, such as formalin-fixed paraffin-embedded (FFPE) tissues.14 
Moreover, the current methods have limited sample throughput, as they require pixel-by-
pixel sample analysis12,13 or high magnification objectives and long exposure time to 
detect protein targets5–11. 
Here, we report a highly sensitive and multiplexed in situ protein analysis approach with 
cleavable fluorescent tyramide (CFT), which is potentially able to quantify >50 different 
proteins in single cells of intact tissues at the optical resolution. As shown in Figure 
3.4.1A, this protein profiling technology consists of three major steps in each analysis 
cycle. First, protein targets are recognized by horseradish peroxidase (HRP) conjugated 
antibodies. HRP catalyzes the coupling reaction between CFT and the tyrosine residues 
on the endogenous proteins in its proximity. In the second step, fluorescence images are 
captured to generate quantitative protein expression profiles. Finally, the fluorophores 
attached to tyramide are chemically cleaved and simultaneously HRP is deactivated, 
which allows the initiation of the next analysis cycle. Through reiterative cycles of target 
staining, fluorescence imaging, fluorophore cleavage, and HRP deactivation, a large 
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number of different proteins with a wide range of expression levels can be quantified in 
single cells of intact tissues in situ.  
3.3 Results and discussion 
To demonstrate the feasibility of this protein profiling approach, we designed and 
synthesized CFT (tyramide-N3-Cy5) (Figure 3.4.1B) by tethering Cy5 to tyramide 
through an azide-based cleavable linker.11 The synthesis and characterization of CFT are 
described in the supporting information.  
We then assessed the detection sensitivity of our approach by comparing it with direct 
and indirect immunofluorescence. Applying these three methods, we stained protein Ki67 
in HeLa cells with primary antibodies of the same concentration (Figure 3.4.2A-C). 
Without loss of the staining resolution, our method is ~88 and ~35 times more sensitive 
than direct and indirect immunofluorescence, respectively (Figure 3.4.2D).  These results 
suggest that the extremely high sensitivity of our approach enables the quantitative 
analysis of low-abundance proteins and dramatically reduces the imaging time.  
A critical requirement for the success of this multiplexed in situ protein profiling 
technology is to efficiently cleave the fluorophores while maintaining the protein 
antigenicity. To search for this optimized cleavage condition, we stained protein Ki67 in 
HeLa cells using HRP conjugated antibodies, tyramide-N3-Cy5 and evaluated the 
fluorophore cleavage efficiencies at different temperatures. After incubating with tris(2-
carboxyethyl)phosphine (TCEP) at 37°C, 50°C and 65°C for 30 minutes, over 85%, 90% 
and 95% of the staining signals were removed, respectively (Figure 3.4.3). To test 
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whether the protein antigenicity remains at varied cleavage temperature, we incubated 
HeLa cells with TCEP at 37°C, 50°C and 65°C for 24 hours, and subsequently stained 
protein Ki67 with tyramide-N3-Cy5. We also labeled protein Ki67 without any pre-
treatment as controls. The cells with the TCEP incubation at 37°C and 50°C have similar 
staining intensities to the control cells; while the cells pretreated at 65°C only have about 
half of the staining intensities compared to the control cells (Figure 3.4.4). We then 
studied the fluorophore cleavage kinetics at 50°C by incubating the stained cells with 
TCEP for 5, 15, 30 and 60 minutes. Among these conditions, 30 minutes is the minimum 
cleavage time required to achieve the maximum cleavage efficiency (Figure 3.4.5).  
These results suggest that the TCEP treatment at 50°C for 30 minutes is the ideal 
condition to efficiently remove the fluorescence signals while preserving the protein 
antigenicity.  
To explore whether TCEP can deactivate HRP and cleave fluorophores simultaneously, 
we stained proteins ILF3 (Figure 3.4.6A), HMGB1, HDAC2, TDP43, PABPN1, hnRNP 
A1, Nucleolin, H4K16ac, hnRNP K and Nucleophosmin (Figure 3.4.7) in HeLa cells 
using HRP conjugated antibodies and tyramide-N3-Cy5. After TCEP incubation at 50°C 
for 30 minutes, the fluorescence signals were efficiently removed, yielding the on/off 
ratios of over 10:1 (Figure 3.4.6B, D, figure 3.4.7). We then incubated the cells with 
tyramide-N3-Cy5 again. For all the proteins under study, no further fluorescence signal 
increases were observed (Figure 3.4.6C, D, figure 3.4.7). These results confirm that the 
protein staining signals generated by CFT can be efficiently erased by TCEP and indicate 
that TCEP can deactivate HRP simultaneously.  
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To test the consistency of protein analysis with CFT between measurements, we labeled 
Nucleolin in Hela cells. After cleavage and HRP deactivation, Nucleolin was stained 
again in the same sets of cells. We repeat the staining of Nucleolin in the same sets of 
cells for 3 cycles. To demonstrate the consistency, we study the correlation of the protein 
expression levels quantified in these 3 cycles (Figure 3.4.8). We got a correlation 
coefficient of 0.96 between the 1st and 2nd cycle, 0.95 between the 1st and 3rd cycle, and 
0.95 between the 2nd and 3rd cycle. High correlations between measurements of the same 
protein in the same cells indicate high consistency of our approach in quantitative 
analysis.  
To demonstrate the feasibility of applying CFT for multiplexed protein analysis, we 
labeled 10 distinct proteins in single HeLa cells in situ. Through reiterative staining 
cycles, proteins HMGB1, HDAC2, TDP43, PABPN1, hnRNP A1, Nucleolin, H4K16ac, 
hnRNP K, ILF3, and Nucleophosmin were unambiguously detected with the HRP 
conjugated antibodies and tyramide-N3-Cy5 in the same set of cells (Figure 3.4.9). We 
also stained these 10 protein targets in 10 different sets of cells by conventional tyramide 
signal amplification (TSA) assays using Cy5 labeled tyramide (Figure 3.4.10). The 
protein distribution patterns obtained by the two methods are consistent with each other. 
We also compared the mean protein abundances per cell measured by our CFT-based 
approach and conventional immunofluorescence with TSA. For all the 10 proteins with 
varied expression levels, the results obtained using the two methods closely resemble 
each other (Figure 3.4.11A). Comparison of the two sets of results yields an R2 value of 
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0.99 with a slope of 1.13 (Figure 3.4.11B). These results indicate that our approach 
allows quantitative and multiplexed protein profiling in individual cells in situ.  
By analyzing the distribution of the single cell protein abundances, we explored protein 
expression heterogeneity in the genetically identical HeLa cells. For all the ten measured 
proteins, the square of the expression standard deviation is much higher than the mean 
expression levels. (Figure 3.4.12A). These results suggest that these proteins are 
generated in translational bursts, rather than at a constant rate.15 We also studied the 
pairwise expression correlation of the ten measured proteins and calculated the 
correlation coefficient of each protein pair (Figure 3.4.12B). Using a hierarchical 
clustering algorithm, we identified a group of eight proteins with substantially correlated 
expression patterns (Figure 3.4.12B). Indeed, all the eight proteins in this identified group 
are involved in the transcriptional regulation and processing related pathways16–23. 
In summary, we have designed and synthesized cleavable fluorescent tyramide, and 
demonstrate the feasibility of this approach in multiplexed protein analysis in cultured 
cells. CFT-based methods achieved an 88-fold signal amplification compared to direct 
immunofluorescence. Compared with the existing multiplexed protein imaging 
technologies, our approach has dramatically enhanced detection sensitivity and sample 
throughput. The number of proteins that can be quantified in single cells using our 
method depends on the number of protein staining cycles. TCEP can efficiently remove 
the fluorophores and simultaneously deactivate HRP within 30 minutes, while the 
antigenicity of protein targets is preserved after incubation with TCEP for at least 24 
hours. Therefore, we envision that this CFA-based approach has the potential to 
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detect >50 protein targets in single cells. With the high sensitivity and multiplexity, CFT-
based approach enables the analysis of proteins expressed in a wide dynamic range. 
Additionally, this approach holds great promise of applications in the protein profiling of 
FFPE tissues. The cleavable fluorescent tyramide developed here can also be applied in 
other areas beyond protein analysis, such as DNA or RNA in situ hybridization24 and 
metabolic analysis. This comprehensive molecular imaging platform will bring new 
insights into cell signaling regulation, cell heterogeneity, cellular microenvironment, 
molecular diagnosis, and cellular targeted therapy.  
3.4 Figures 
 
Figure 3.4.1. A) Highly sensitive and multiplexed in situ protein profiling with 
cleavable fluorescent tyramide. Protein targets are stained with HRP conjugated 
antibodies and cleavable fluorescent tyramide. After imaging, the fluorophores are 
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chemically cleaved and simultaneously the HRP is deactivated. Through cycles of 
target staining, fluorescence imaging, fluorophore cleavage and HRP deactivation, 
comprehensive protein profiling can be achieved in single cells in situ. B) Structure of 
cleavable fluorescent tyramide, tyramide-N3-Cy5.   
 
 
Figure 3.4.2. Protein Ki67 in HeLa cells are stained by (A) direct immunofluorescence 
(IF), (B) indirect IF, and (C) cleavable fluorescent tyramide (CFT). The images in (A), 
(B) and (C) are captured with the exposure time of 1 second, 300 millisecond, and 15 
milliseconds, respectively. (D) Normalized staining intensities of 30 different positions 
in (A), (B) and (C). The y-axis in (D) is on a logarithmic scale. Scale bars, 25 µm. 
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Figure 3.4.3. (A) Protein Ki67 in HeLa cells is stained with tyramide-N3-Cy5. (B) The 
stained cells are incubated with TCEP at 37°C for 30 minutes. (C) Fluorescence 
intensity profile corresponding to the red line and green line positions in (A) and (B). 
(D) Protein Ki67 in HeLa cells is stained with tyramide-N3-Cy5. (E) The stained cells 
are incubated with TCEP at 50°C for 30 minutes. (F) Fluorescence intensity profile 
corresponding to the red line and green line positions in (D) and (E). (G) Protein Ki67 
in HeLa cells is stained with tyramide-N3-Cy5. (H) 
The stained cells are incubated with TCEP at 65°C for 30 minutes. (I) Fluorescence 
intensity profile corresponding to the red line and green line positions in (G) and (H). 
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(J) Fluorophore cleavage efficiency at different reaction temperatures (n = 30 
positions). Scale bars, 20 µm. 
 
 
Figure 3.4.4. After incubation with TCEP at (A) 37°C, (B) 50°C and (C) 65°C for 24 
hours, or (D) without any TCEP pre-treatment, protein Ki67 in HeLa cells is stained 
with tyramide-N3-Cy5. (E) The obtained signal intensities with TCEP pre-treatment at 
different temperatures and without any pre-treatment (control) (n = 30 positions). Scale 
bars, 20 µm. 
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Figure 3.4.5. A) Protein Ki67 in HeLa cells is stained with tyramide-N3-Cy5. (B) The 
stained cells are incubated with TCEP at 50°C for 5 minutes. (C) Fluorescence 
intensity profile corresponding to the red line and green line positions in (A) and (B). 
(D) Protein Ki67 in HeLa cells is stained with tyramide-N3-Cy5. (E) The stained cells 
are incubated with TCEP at 50°C for 15 minutes. (F) Fluorescence intensity profile 
corresponding to the red line and green line positions in (D) and (E). (G) Protein Ki67 
in HeLa cells is stained with tyramide-N3-Cy5. (H) The stained cells are incubated with 
TCEP at 50°C for 30 minutes. (I) Fluorescence intensity profile corresponding to the 
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red line and green line positions in (G) and (H). (J) Protein Ki67 in HeLa cells is 
stained with tyramide-N3-Cy5. (K) The stained cells are incubated with TCEP at 50°C 
for 60 minutes. (L) Fluorescence intensity profile corresponding to the red line and 
green line positions in (J) and (K). (M) Fluorophore cleavage efficiency at different 
reaction time (n = 30 positions). Scale bars, 20 µm. 
 
 
Figure 3.4.6. A) Protein ILF3 in HeLa cells is stained with HRP conjugated antibodies 
and tyramide-N3-Cy5. B) Cy5 is cleaved by TCEP. C) Cells are incubated with 
tyramide-N3-Cy5, again. D) Fluorescence intensity profile corresponding to the red, 
blue and green line positions in (A), (B) and (C). Scale bars, 20 μm.  
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Figure 3.4.7. Different proteins in HeLa cells are stained with HRP conjugated 
antibodies and tyramide-N3-Cy5 (the first column). The stained cells are incubated 
with TCEP (the second column). Subsequently, the cells are incubated with tyramide-
N3-Cy5, again (the third column). Fluorescence intensity profiles corresponding to the 
red, blue and green line positions in the staining, cleavage and restaining images (the 
fourth column). Scale bars, 15 μm. 
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Figure 3.4.8. Correlation between 3 cycles of Nucleolin staining in Hela cells. Scatter 
plot of measurements from A) the 1st and 2nd cycle indicates a correlation coefficient of 
0.96, B) the 1st and 3rd cycle indicated a correlation coefficient of 0.95, and C) the 2nd 
and 3rd cycle indicates a correlation coefficient of 0.95. 
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Figure 3.4.9. 10 different proteins are stained sequentially with the corresponding HRP 
conjugated antibodies and tyramide-N3-Cy5 in the same set of HeLa cells. Scale bars, 
40 μm. 
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Figure 3.4.10. 10 different proteins are stained with the corresponding HRP 
conjugated antibodies and Cy5 labeled tyramide in different HeLa cells. Scale bars, 40 
μm. 
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Figure 3.4.11. (A) Mean expression level per cell (n = 200 cells) of 10 different 
proteins measured by immunofluorescence (IF) with cleavable fluorescent tyramide 
(CFT) and conventional immunofluorescence with tyramide signal amplification 
(TSA). (B) Comparison of the results obtained by immunofluorescence with CFT and 
TSA yields R2 = 0.99 with a slope of 1.13. The x and y axes in (B) are on a logarithmic 
scale. 
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Figure 3.4.12. Protein expression heterogeneity and correlation. (A) Histograms of the 
expression level per cell of the 10 measured proteins. (B) Correlation of the expression 
levels of the 10 measured proteins and the hierarchical clustering tree. The upper 
triangle shows the expression correlation coefficient of each protein pair. The lower 
triangle displays the color corresponding to the correlation coefficient. And the protein 
names are shown in the diagonal. A group of proteins identified by a threshold on the 
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cluster tree (dashed line) is indicated by the black box in the matrix and the red lines on 
the tree. 
 
3.5 Schemes 
 
Scheme 3.5.1. Synthesis of tyramide-N3-Cy5. Reagents and conditions: (i) DSC, 
DMAP, DMF, rt, 30 min; and then tyramine hydrochloride, DIPEA, rt, 2 h. 
 
3.6 Methods 
3.6.1. General information 
Chemicals and solvents were purchased from Sigma-Aldrich or TCI America and were 
used directly without further purification, unless otherwise noted. Bioreagents were 
purchased from Invitrogen, unless otherwise indicated. 1H-NMR and 13C-NMR were 
taken on Varian Innova 500 MHz NMR spectrometers. Chemical shifts are reported in 
parts permillion (ppm) downfield from tetramethylsilane (TMS). Data are reported as 
follows: chemicalshift, multiplicity: singlet (s), doublet (d), triplet (t), multiplet (m), 
coupling constants J in Hz, and integration. HRMS was performed by the Arizona State 
University mass spectrometry facility. 
3.6.2. Synthesis of the tyramide-N3-Cy5 (Scheme 3.5.1) 
Tyramide-N3-Cy5 (2): The compound 1 prepared accordingly to the literature11 was 
further purified by semi-preparative reverse phase HPLC [HPLC gradient: A, 100% 0.1 
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M TEAA; B, 100% MeCN; 0-2 min, 5% B (flow 2-5 ml/min); 2-15 min, 5-22% B (flow 
5 ml/min); 15-20 min, 22-30% B (flow 5 ml/min); 20-30 min, 30-35% B (flow 5 
ml/min); 30-32 min, 35-95% B (flow 5 ml/min); 32-35 min, 95% B (flow 5 ml/min); 35-
37 min, 95-5% B (flow 5 ml/min); 37-40 min, 5% B (flow 5-2 ml/min)]. The fraction 
with retention time 25.6 min was collected and dried completely under reduced pressure. 
The purified compound 1 (3.9 mg, 4.86 μmol) was co-evaporated with anhydrous DMF 
(1 ml) and then dissolved in anhydrous DMF (300 μL). N, N'-disuccinimidyl carbonate 
(DSC) (6.2 mg, 24.3 μmol) in 40 μL of anhydrous DMF and 4-dimethylaminopyridine 
(DMAP) (3.0 mg, 24.3 μmol) were added to the above solution and the reaction mixture 
was stirred for 30 min at room temperature. Subsequently, to this reaction mixture 
tyramine hydrochloride (4.2 mg, 24.3 μmol) and N, N-diisopropylethylamine (DIPEA) 
(8.2 μL, 48.6 μmol) were added and the reaction mixture was stirred for 2 h at room 
temperature. After completion of the reaction, DMF was evaporated completely under 
reduced pressure. The crude product was purified by a preparative silica gel TLC plate 
(25 X 25 cm; silica gel 60; CH3OH:CH2Cl2 = 1:6; Rf = 0.2). Subsequently, the residue 
was dissolved in 0.1 M TEAA buffer/10% CH3CN followed by filtering off undissolved 
materials by nylon syringe filter (0.2 UM). Then the product was further purified by 
semi-preparative reverse phase HPLC [HPLC gradient: A, 100% 0.1 M TEAA; B 100% 
MeCN; 0-2 min, 5% B (flow 2-5 ml/min); 2-10 min, 5-22% B (flow 5 ml/min); 10-15 
min, 22-30% B (flow 5 ml/min); 15-20 min, 30-40% B (flow 5 ml/min); 20-25 min, 40-
50% B (flow 5 ml/min); 25-30 min, 50-60% B (flow 5 ml/min); 30-32 min, 60-70% B 
(flow 5 ml/min); 32-35 min, 70-95% B (flow 5 ml/min); 35-37 min, 95% B (flow 5 
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ml/min); 37-39 min, 95-5% B, (flow 5 ml/min); 39-42 min, 5% B (flow 5-2 ml/min)]. 
The fraction with retention time 14.1 min was collected and dried completely under 
reduced pressure. The residue was co-evaporated twice with water (2 ml) to afford 
compound 2 (1.1 mg, 24%) as a pure blue solid. 1H NMR (500 MHz, CD3OD) δ 8.05-
7.96 (m, 2H), 7.87-7.77 (m, 4H), 7.29 (dd, J = 22.1, 8.4 Hz, 2H), 6.98 (d, J = 7.4 Hz, 2H), 
6.70 (d, J = 8.1 Hz, 2H), 6.55-6.47 (m, 1H), 6.22 (dd, J = 24.1, 13.4 Hz, 2H), 4.60 (t, J = 
5.9 Hz, 1H), 4.16-3.97 (m, 6H), 3.89-3.84 (m, 1H), 3.73-3.64 (m, 2H), 3.21-3.10 (m, 4H), 
2.59-2.52 (m, 2H), 2.19-2.12 (m, 2H), 1.83-1.70 (m, 4H), 1.70-1.53 (m, 12H), 1.35-1.22 
(m, 6H); HRMS (ESI-, m/z) calcd for C47H58N7O11S2 [(M)-]: 960.3636, found: 
960.3074. 
3.6.3. Protein staining with cleavable fluorescent tyramide (CFT) in cells 
Cell culture 
HeLa CCL-2 cells (ATCC) were maintained in Dulbelcco’s modified Eagle’s Medium 
(DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 g/mL 
streptomycin in a humidified atmosphere at 37 °C with 5% CO2. Cells were plated on 
chambered coverglass (0.2 ml medium/chamber) (Thermo Fisher Scientific) and allowed 
to reach 60% confluency in 1-2 days. 
Cell fixation 
Cultured HeLa CCL-2 cells were fixed with 4% formaldehyde at 37°C for 15 min, 
permeabilized with 0.1% (vol/vol) Triton X-100 at room temperature for 15 min, and 
washed 3 times with 1X phosphate-buffered saline (PBS), each for 5 min. 
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Endogenous peroxidase blocking 
Fixed and permeabilized HeLa CCL-2 cells were incubated with 0.15% H2O2 in PBT (1X 
PBS, 0.1% (vol/vol) Triton X-100) for 10 min, and then washed 3 times with 1X PBS, 
each for 5 min. 
Immunofluorescence with CFT 
Fixed and permeabilized HeLa CCL-2 cells were first blocked with 1X blocking buffer 
(1% (wt/vol) bovine serum albumin, 0.1% (vol/vol) Triton X-100, 10% (vol/vol) normal 
goat serum) at room temperature for 1 h. The cells were incubated with HRP conjugated 
primary antibodies at a concentration of 5 μg/mL in 1X blocking buffer for 45 min, and 
then washed 3 times with PBT, each for 5 min. Subsequently, cells were incubated with 
10 pmol/μL tyramide-N3-Cy5 in amplification buffer (0.1 M Boric acid, pH=8.5) for 7 
min. Cells were quickly washed twice with PBT, followed by 5 min wash with PBT for 3 
times. Stained cells were washed with GLOX buffer (0.4% glucose and 10 mM Tris HCl 
in 2X saline-sodium citrate (SSC) buffer (300 mM sodium chloride, 30 mM trisodium 
citrate, pH = 7.0)) for 1 min at room temperature, and then imaged in GLOX solution 
(0.37 mg mL-1 glucose oxidase and 1% catalase in GLOX buffer). The used primary 
antibodies include HRP conjugated rabbit anti-HMGB1 (Thermo Fisher Scientific; PA5- 
22722), HRP conjugated rabbit anti-HDAC2 (Abcam; ab195851), HRP conjugated rabbit 
anti-TDP43 (Abcam; ab193850), HRP conjugated rabbit anti-PABPN1 (Abcam; 
ab207515), HRP conjugated rabbit anti-hnRNP A1 (Abcam; ab198535), HRP conjugated 
mouse anti Nucleolin (Abcam; ab198492), HRP conjugated rabbit anti-Histone H4 
(acetyl K16) (Abcam; ab200859), HRP conjugated mouse anti-hnRNP K (Abcam; 
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ab204456), HRP conjugated rabbit anti-ILF3 (Abcam; ab206250) and HRP conjugated 
mouse anti-Nucleophosmin (Abcam; ab202579). 
To stain protein Ki67, fixed and blocked HeLa CCL-2 cells were incubated with 5 μg/mL 
rabbit anti-Ki67 (Thermo Fisher Scientific; RB1510P1ABX) in 1X blocking buffer for 45 
min, and then washed 3 times with PBT, each for 5 min. Afterwards, cells were incubated 
with 5 μg/mL HRP conjugated goat-anti-rabbit (Thermo Fisher Scientific; A16110) in 
1% (wt/vol) bovine serum albumin in PBT for 30 min, followed by 3 times wash with 
PBT, each for 5 min. Subsequently, cells were incubated with 10 pmol/μL tyramide-N3-
Cy5 in amplification buffer for 7 min. Cells were quickly washed twice with PBT, 
followed by 5 min wash with PBT for 3 times. Cells were then imaged in GLOX 
solution. 
Fluorophore cleavage and HRP deactivation 
To remove the fluorophores and simultaneously deactivate horseradish peroxidase 
(HRP), cells were incubated with tris(2-carboxyethyl)phosphine (TCEP) (100 mM, 
pH=9.5) at 50°C for 30 minutes. To explore the cleavage efficiencies under different 
temperatures, cells were incubated with TCEP (100 mM, pH=9.5) at 37°C, 50°C and 
65°C for 30 minutes. To study the cleavage kinetics, cells were incubated with TCEP 
(100 mM, pH=9.5) at 50°C for 5, 15, 30 and 60 minutes. Following the TCEP incubation, 
cells were washed 3 times with PBT and 3 times with 1X PBS, each for 5 min. Cells were 
then imaged in GLOX solution. To evaluate the HRP deactivation efficiencies following 
the TCEP incubation, cells were incubated with 10 pmol/μL 
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tyramide-N3-Cy5 in amplification buffer for 7 min. After 2 times quick wash and 3 times 
5 min wash with PBT, cells were imaged in GLOX solution. 
3.6.4. Conventional immunofluorescence 
The Cy5 labeled primary and secondary antibodies were prepared accordingly to the 
literature11. For direct immunofluorescence, fixed and blocked HeLa CCL-2 cells were 
incubated with 5 μg/mL Cy5 labeled rabbit anti-Ki67 primary antibodies (Thermo Fisher 
Scientific; RB1510P1ABX) in the 1X blocking buffer for 45 min at room temperature. 
Cells were washed 3 times with PBT, each for 5 min, and then imaged. For indirect 
immunofluorescence, fixed and blocked HeLa CCL-2 cells were incubated with 5 μg/mL 
rabbit anti-Ki67 (Thermo Fisher Scientific; RB1510P1ABX) for 45 min in 1X blocking 
buffer, then washed 3 times with PBT, each for 5 min. Then cells were incubated with 5 
μg/mL Cy5 labeled goat-anti-rabbit (Thermo Fisher Scientific; A16112) in 1% (wt/vol) 
bovine serum albumin in PBT for 30 min, followed by 3 times wash with PBT, each for 5 
min. Cells were then imaged in GLOX solution. 
3.6.5 3-cycle staining of Nucleolin with CFT in Hela cells 
Fixed and blocked HeLa CCL-2 cells were incubated with 0.5 μg/mL HRP conjugated 
Nucleolin at room temperature for 45 min, and then stained by tyramide-N3-Cy5. After 
imaging, stained cells were incubated with 100 mM TCEP (pH=9.5) at 50°C for 30 min, 
followed by the cycle of staining. Nucleolin is stained in the same sets of cells for 
continuously 3 cycles. 
3.6.6 Multiplexed protein analysis with CFT in cells 
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Fixed and blocked HeLa CCL-2 cells were incubated with 5 μg/mL HRP conjugated 
primary antibodies at room temperature for 45 min, and then stained by tyramide-N3-
Cy5. After imaging, stained cells were incubated with 100 mM TCEP (pH=9.5) at 50°C 
for 30 min, followed by the next immunofluorescence cycle. The sequentially used 
primary antibodies include HRP conjugated rabbit anti-HMGB1 (Thermo Fisher 
Scientific; PA5-22722), HRP conjugated rabbit anti-HDAC2 (Abcam; ab195851), HRP 
conjugated rabbit anti-TDP43 (Abcam; ab193850), HRP conjugated rabbit anti-PABPN1 
(Abcam; ab207515), HRP conjugated rabbit anti-hnRNP A1 (Abcam; ab198535), HRP 
conjugated mouse anti-Nucleolin (Abcam; ab198492), HRP conjugated rabbit anti-
Histone H4 (acetyl K16) (Abcam; ab200859), HRP conjugated mouse anti-hnRNP K 
(Abcam; ab204456), HRP conjugated rabbit anti-ILF3 (Abcam; ab206250) and HRP 
conjugated mouse anti-Nucleophosmin (Abcam; ab202579). For control experiments, 
fixed and blocked HeLa CCL-2 cells were incubated with 5 μg/mL HRP conjugated 
primary antibodies at room temperature for 45 min, and then stained by Cy5 labeled 
tyramide (PerkinElmer). 
3.6.7 Imaging and data analysis 
Stained cells were imaged under a Nikon Ti-E epifluorescence microscope equipped with 
20X objective. Images were taken using a CoolSNAP HQ2 camera and Chroma filter 
49009. Cell segmentation and intensity quantification were processed by NIS-Elements 
Imaging software. Pseudo-color images were generated using ImageJ. Protein expression 
heterogeneity and correlation were analyzed with Excel (Microsoft). The hierarchical 
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clustering was performed with Cluster 3.0 
(http://bonsai.hgc.jp/~mdehoon/software/cluster/).  
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CHAPTER 4 
MULTIPLEXED SINGLE CELL IN SITU PROTEIN ANALYSIS REVEALS 
NEURONAL HETEROGENEITY IN THE HUMAN HIPPOCAMPUS 
4.1 Abstract 
Formalin-fixed, paraffin-embedded (FFPE) tissue is the most common type of preserved 
clinical samples and used extensively in diagnosis and disease study. However, due to its 
high autofluorescence, with the low detection sensitivity of the existing methods, it’s 
technically challenging to achieve protein profiling in FFPE tissues. We have developed 
a highly multiplexed and sensitive in situ protein profiling method with cleavable 
fluorescent tyramide (CFT). Here we applied this approach and studied 8 different 
proteins in the FFPE tissue of human hippocampus. We collected the protein expression 
profile of 8 proteins in thousands of neurons in the human hippocampus. The results 
reveal the neuronal heterogeneity in distinct subregions of human hippocampus. 
4.2 Introduction 
As the most common type of preserved clinical samples, formalin-fixed paraffin-
embedded (FFPE) tissues are extensively used for routine diagnosis and studies of 
disease mechanisms1. There are two major challenges to analyze the biomolecules from 
FFPE tissues. Firstly, although FFPE tissues are well preserved, due to the method of 
preservation and the longtime storage, the biomolecules might be partially degraded2,  
which make the retrieval of the biomolecule information from FFPE tissues to be 
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difficult. Secondly, FFPE tissues are highly autofluorescent3, which improve the 
difficulty of distinguishing real signal from background. 
Recently, a number of methods have been explored to enable multiplexed in situ protein 
analysis4–11. Nonetheless, with the detection tags directly conjugated to antibodies, the 
existing methods have low detection sensitivity. This limitation hinders their applications 
to study proteins in FFPE tissues. In Chapter 2, we discussed a highly sensitive and 
multiplexed in situ protein profiling method with cleavable fluorescent tyramide (CFT), 
which is a promising method in protein profiling in FFPE tissues.  
Here, we demonstrated the feasibility of applying CFT in the protein profiling of cells in 
FFPE tissues. We studied 8 proteins sequentially in the human hippocampus using HRP 
conjugated antibodies and CFTs. 8-cycle images were then converted into a protein 
expression profile of thousands of neurons in the human hippocampus. With viSNE12, a 
dimensionality reduction algorithm, 10 different clusters of neurons was distinguished. 
By combining the natural coordination of the neurons in the tissue, we visualized the 
distributions of the neuron clusters in the distinct subregions of the human hippocampus. 
These results reveal the neuronal heterogeneity in the human hippocampus. 
4.3 Results and discussion 
We stained 8 proteins sequentially in the human hippocampus using HRP conjugated 
antibodies and tyramide-N3-Cy5. With 8 reiterative staining cycles, proteins NeuN, 
PABPN1, HMGB1, TDP43, hnRNP A1, hnRNP K, ILF3, and Nucleophosmin were 
successfully detected in the FFPE tissue (Figure 4.4.1).  
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With the multiplexed single-cell in situ protein profiling results, we explored the neuronal 
heterogeneity and their spatial organization in the human hippocampus. In the examined 
tissue, we calculated the protein expression levels in >6000 individual neurons, which 
were identified by the neuronal marker NeuN.13 We then applied the software viSNE12 to 
partition the individual neurons into 10 clusters (Figure 4.4.2A) based on their protein 
expression profiles (Figure 4.4.3, figure 4.4.4). By analyzing the protein expression level 
patterns of different clusters, we would be able to discover new biomarkers. For example, 
hnRNP K could be a marker for cluster 2 neurons, because it’s highly regulated in cluster 
2 neurons and down-regulated in all other clusters. Additionally, high expression levels 
of PABPN1, TDP43, and ILF3 distinguish cluster 8 neurons from all other clusters. 
Cluster 7 neurons show a special feature in high expression levels of PABPN1, ILF3 and 
extremely low expression in TDP43. Without immense prior knowledge of protein 
expressions in neurons, these results facilitate the discoveries of different cell clusters and 
new biomarkers. 
By mapping these 10 clusters of cells back to their natural locations in the tissue (Figure 
4.4.2B, figure 4.4.5, figure 4.4.6), we observed that different subregions of the 
hippocampus consist of neurons from distinct clusters. For example, the dentate gyrus 
(DG) contains all the clusters except cluster 7, while the Cornu Ammonis (CA) fields are 
dominated by clusters 3, 6, 7, and 8. Within the CA fields, cluster 7 only appears in CA1, 
CA2, and CA3, but not in CA4 (Figure 4.4.7A). In the DG, cluster 2 is the major cell 
class in the regions of interest (ROI) 1-5. In contrast, other subregions of the DG are 
mainly composed of clusters 1, 3, 4, 9 and 10 (Figure 4.4.7B).  
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In summary, we have successfully applied CFTs in the protein profiling of single cells in 
FFPE tissues in situ. Using this approach, we have shown that different subregions of the 
human hippocampus consist of varied neuron clusters. These results suggest that our 
approach enables multiplexed single-cell in situ protein profiling in FFPE tissues, also 
allows the investigation of the different cell type compositions and their spatial 
organizations in intact tissues. The number of proteins that can be quantified in one tissue 
section using our method depends on the number of protein staining cycles. In chapter 3, 
we demonstrated TCEP can efficiently remove the fluorophores and simultaneously 
deactivate HRP within 30 minutes, while the antigenicity of protein targets is preserved 
after incubation with TCEP for at least 24 hours. Therefore, we envision that this CFA-
based approach has the potential to detect >50 protein targets in the same tissue. This 
approach will provide a promising tool for tissue-based clinical diagnosis and disease 
mechanism studies.  
4.4 Figures 
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Figure 4.4.1. Eight different proteins are detected sequentially with HRP conjugated 
antibodies and tyramide-N3-Cy5 in the FFPE human brain tissue. Scale bars, 200 μm. 
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Figure 4.4.2. A) Over 6000 neurons in a human hippocampus are partitioned into 10 
clusters. B) Anatomical locations of the individual neurons from the 10 clusters in the 
DG (1-17), CA1 (a-e), CA2 (f), CA3 (g, h) and CA4 (i-k). Scale bars, 2 mm. 
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Figure 4.4.3. Distribution of single-cell protein expression in viSNE plots 
 
95 
 
 
Figure 4.4.4. The distinct protein expression patterns in the 10 cell clusters and the 
percentage of cells in each cluster. 
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Figure 4.4.5. Zoom-in views of different regions of interest (ROI) in the dentate gyrus 
(DG) in Figure 4B. Scale bars, 200 μm. 
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Figure 4.4.6. Zoom-in views of different ROI in the Cornu Ammonis (CA) fields in 
Figure 4B. Scale bars, 500 μm. 
 
98 
 
 
99 
 
Figure 4.4.7. (A) The DG and CA fields are composed of neurons from different cell 
clusters. (B) Varied ROI in the DG are composed of neurons from different cell 
clusters. 
 
4.5 Methods 
4.5.1 General information 
Chemicals and solvents were purchased from Sigma-Aldrich or TCI America and were 
used directly without further purification, unless otherwise noted. Bioreagents were 
purchased from Invitrogen, unless otherwise indicated. 
4.5.2 Multiplexed protein analysis with CFT in brain tissues 
Deparaffinization and antigen retrieval 
The brain formalin-fixed paraffin-embedded (FFPE) tissue slide was deparaffinized 3 
times in xylene, each for 10 min. Then, the slide was immersed in 100% ethanol for 2 
min, 95% ethanol for 1 min, 70% ethanol for 1 min, 50% ethanol for 1 min, 30% ethanol 
for 1 min, and rinsed with deionized water. Subsequently, the slide was immersed in 
antigen retrieval buffer (10 mM sodium citrate, 0.05% Tween 20, pH=6.0), and 
waterbathed in a pressure cooker for 20 min with the “high pressure” setting. Afterwards, 
the slide was rinsed 3 times with 1X PBS, each for 5 min. 
Multiplexed protein staining in FFPE tissues 
After deparaffinization and antigen retrieval, the brain FFPE tissue was first blocked by 
0.15% H2O2 for 10 min and then washed 3 times with 1X PBS, each for 5 min. The tissue 
was then blocked in 1X blocking buffer at room temperature for 1 h. Subsequently, the 
tissue was incubated with 5 μg/mL biotin conjugated Rabbit anti-NeuN (Abcam; 
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ab204681) in 1X blocking buffer for 45 min, and then washed 3 times with PBT, each for 
5 min. Afterwards, the tissue was incubated with 5 μg/mL HRP conjugated streptavidin 
(Abcam; ab7403) in 1% (wt/vol) bovine serum albumin in PBT for 30 min, followed by 3 
times wash with PBT, each for 5 min. Subsequently, the tissue was incubated with 10 
pmol/μL tyramide-N3-Cy5 in amplification buffer for 7 min. The tissue was quickly 
washed twice with PBT, followed by 5 min wash with PBT for 3 times. After imaging, 
the tissue was incubated with 100 mM TCEP (pH=9.5) at 50°C for 30 min. The tissue 
was imaged again before initiating the next cycle. In the following cycles, the tissue was 
incubated with 5 μg/mL HRP conjugated primary antibodies in 1X blocking buffer for 45 
min. Subsequently, the tissue was stained with tyramide-N3-Cy5 and imaged. After 
incubated with 100 mM TCEP (pH=9.5) at 50°C for 30 min, the tissue was imaged again, 
followed by the next analysis cycle. The sequentially used primary antibodies include 
HRP conjugated rabbit anti-PABPN1 (Abcam; ab207515), HRP conjugated rabbit anti-
HMGB1 (Thermo Fisher Scientific; PA5-22722), HRP conjugated rabbit anti-TDP43 
(Abcam; ab193850), HRP conjugated rabbit anti-hnRNP A1 (Abcam; ab198535), HRP 
conjugated mouse anti-hnRNP K (Abcam; ab204456), HRP conjugated rabbit anti-ILF3 
(Abcam; ab206250) and HRP conjugated mouse anti-Nucleophosmin (Abcam; 
ab202579). 
4.5.3 Imaging and data analysis 
FFPE brain tissue were imaged under a Nikon Ti-E epifluorescence microscope equipped 
with 20X objective. Images were taken using a CoolSNAP HQ2 camera and Chroma 
filter 49009. Cell segmentation and intensity quantification were processed by NIS-
101 
 
Elements Imaging software. Pseudo-color images were generated using ImageJ. ViSNE 
maps were generated from CYT 
(https://www.c2b2.columbia.edu/danapeerlab/html/cyt.html)12. 
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CHAPTER 5 
SUMMARY 
In summary, we have designed and synthesized an azide-based cleavable linker. We 
applied this linker to develop new fluorescent probes which can be used in multiplexed 
protein analysis in single cells. With cleavable fluorescent antibodies, we can detect >100 
proteins in situ in single cells. Additionally, with cleavable fluorescent tyramide, the 
detection sensitivity is dramatically increased. We demonstrated the feasibility of 
cleavable fluorescent tyramide to detect >50 protein targets in formalin-fixed, paraffin-
embedded (FFPE) tissue samples. We applied cleavable fluorescent tyramide in the 
protein analysis of the human hippocampus tissues. By analyzing >6000 neurons in the 
human hippocampus, we studied the neuronal heterogeneity and their spatial distribution. 
This approach enables to study the functional heterogeneity of subregions in human 
hippocampus and development of disease such as Alzheimer’s.  
The development of single-cell proteomics will boost our understanding of systems 
biology and disease development. For example, by analyzing proteins in the single-cell 
level of the human hippocampus of healthy and Alzheimer’s donors, researchers can 
identify cells of abnormal protein expressions, then find biomarkers for Alzheimer’s. By 
localizing disease cells in the subregions of the human brains, we can study the 
development of Alzheimer’s disease and how it affects brain functions.  
Single-cell proteomics will also have broad applications in diagnosis, personalized 
medicine, and prognosis. Tumor cells can be identified in early stage so that precision 
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diagnosis can be achieved. By studying proteins in tumors in the single-cell level, the 
subtypes of tumor cells can be distinguished. This study will facilitate personalized 
medicine. Additionally, studying the interactions between tumor cells and immune cells 
will help the prognosis of tumor patients. Single-cell proteomics, together with other 
‘omics’ studies, such as genomics, transcriptomics, and metabolomics, will help to 
provide a global map of biomolecules and bring new insights to cell studies. 
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